hg_166081.1

Basic information about the TSS

---

TSS ID: hg_166081.1 Species: human Chr: chr17		Start: 42017411 End: 42017466 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000316603.12 ENST00000457167.9 ENST00000586335.2 ENST00000674306.1 ENST00000674504.1 ENST00000674472.1 ENST00000674233.1 ENST00000674481.1 ENST00000585866.6 ENST00000588814.5 ENST00000674453.1 ENST00000585693.2 ENST00000674175.1 ENST00000588641.6 ENST00000674425.1 BC011837 U46571 BC033772 AK296602 AK316081 AB587519 AM393511 CU680076 Distance: 0 GeneID: 7266 HGNC/MGI_ID: HGNC:12392 UniProt_ID: A0A6I8PIK4 A0A6I8PR89 A0A6I8PU73 A0A6I8PU89 B4DKK3 B7Z9W6 K7EJ24 K7ELJ8 K7ENB7 K7ESP1 Q99615

Gene_name: DnaJ heat shock protein family (Hsp40) member C7 Gene_symbol: DNAJC7 Gene_synonyms: TPR2 Gene_source: HGNC:12392

TATA-Box annotation

---

Distance to TSS:	0
Nearest PromoterID:	NM_003315
Entrez ID:	7266
Nearest Unigene:	Hs.500156
Nearest Refseq:	NM_003315
Nearest Ensembl:	ENSG00000168259
Gene Name:	DnaJ heat shock protein family (Hsp40) member C7
Gene Alias:	DJ11|DJC7|TPR2|TTC2
Gene Description:	DnaJ heat shock protein family (Hsp40) member C7
Gene Type:	protein-coding
CpG%:	0.115
GC%:	0.686567
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DNAJC7 p2@DNAJC7 p3@DNAJC7 p4@DNAJC7 p5@DNAJC7 p6@DNAJC7 p7@DNAJC7 p8@DNAJC7 p9@DNAJC7 p10@DNAJC7
Sample		p1@DNAJC7	p2@DNAJC7	p3@DNAJC7	p4@DNAJC7	p5@DNAJC7	p6@DNAJC7	p7@DNAJC7	p8@DNAJC7	p9@DNAJC7	p10@DNAJC7
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	88.05	3.90	3.12	2.14	0.19	0.39	0.78	4.68	2.92	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	78.09	3.24	1.82	3.44	0.40	0.40	0.61	2.63	2.43	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	89.89	3.28	5.02	3.67	0.19	0.00	0.39	3.09	2.70	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	64.66	2.49	3.33	2.91	0.00	0.42	0.21	3.53	2.49	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	70.41	1.57	2.02	1.35	0.22	0.45	0.00	5.40	1.80	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	75.78	2.52	3.29	3.49	0.19	0.00	0.19	2.91	2.52	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	114.61	4.14	5.01	3.49	0.44	0.65	0.87	7.63	5.23	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	75.09	3.39	2.91	2.66	0.00	0.00	0.00	3.88	2.66	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	79.50	2.35	1.92	3.85	0.21	0.21	0.00	3.42	2.56	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	80.57	2.90	7.54	2.90	0.58	0.58	0.58	2.32	6.96	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	76.40	3.64	5.26	2.02	0.40	0.00	0.00	2.02	6.47	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	84.16	0.81	5.29	3.25	0.41	0.81	0.41	3.66	4.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	31.11	4.19	0.48	0.00	0.97	0.32	0.00	2.90	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	28.12	2.86	1.20	0.15	0.45	0.15	0.00	2.26	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	29.86	2.42	0.44	0.22	0.44	0.66	0.00	1.98	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	27.92	1.51	0.75	0.00	1.01	0.75	0.00	2.51	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	29.27	1.75	1.09	0.00	0.44	0.00	0.00	1.31	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	26.15	2.53	0.42	0.00	0.00	0.42	0.00	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	21.86	2.67	0.53	0.00	0.00	0.00	0.00	2.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	27.08	2.26	1.05	0.75	1.65	0.75	0.00	1.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	31.27	1.74	0.67	0.53	1.07	0.80	0.00	1.34	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	30.90	2.24	1.21	0.17	0.17	0.35	0.00	1.73	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	29.86	3.36	0.26	0.00	0.65	0.39	0.00	0.78	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	26.69	2.67	1.46	0.73	0.00	0.49	0.00	1.70	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	25.54	1.81	1.81	0.00	0.77	0.26	0.26	2.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	23.11	3.48	1.27	1.58	0.63	0.32	0.00	1.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	26.92	2.75	1.65	0.55	1.10	0.00	0.00	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	36.54	2.59	0.24	0.94	0.94	0.47	0.00	1.18	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.49	2.58	1.45	0.48	0.16	0.32	0.00	1.62	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	29.86	2.90	1.45	0.36	0.54	1.09	0.00	1.81	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	22.61	2.09	0.84	0.21	0.63	0.21	0.00	1.67	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.79	3.13	0.98	0.20	1.76	0.59	0.20	2.34	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	23.21	3.59	1.27	0.21	0.42	0.00	0.21	2.53	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	36.29	3.46	1.15	0.49	0.33	0.33	0.00	3.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.98	2.43	0.75	0.19	0.56	0.00	0.00	1.50	0.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	27.98	2.11	0.77	0.00	0.00	0.19	0.00	1.92	0.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	24.73	1.84	1.64	0.41	1.02	0.61	0.00	2.45	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	25.39	1.81	1.41	0.20	0.81	0.40	0.40	0.81	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	33.49	1.89	1.35	1.08	0.81	0.00	0.00	1.08	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	28.57	2.40	0.48	0.24	1.20	0.24	0.00	1.92	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	25.64	1.41	0.47	0.71	0.94	0.24	0.24	1.41	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	30.16	1.90	1.46	0.59	0.59	0.59	0.15	1.02	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	23.83	1.69	1.05	0.42	0.63	0.42	0.00	0.63	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	23.25	2.27	0.70	0.52	0.52	0.17	0.17	1.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	33.93	2.61	1.20	0.40	0.80	0.60	0.00	2.21	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	20.94	2.33	0.47	0.00	0.93	0.23	0.23	1.16	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.95	2.88	1.68	0.00	0.96	0.72	0.00	1.20	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	24.44	1.79	0.00	0.60	0.89	0.00	0.30	1.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	24.66	1.68	1.20	0.96	0.48	0.24	0.00	1.91	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	24.06	2.22	1.42	0.20	1.82	0.40	0.00	2.83	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	22.54	2.25	1.02	1.23	0.61	0.61	0.41	2.05	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	23.79	2.89	1.11	1.11	0.89	0.44	0.00	1.78	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	349.80	13.99	27.98	0.00	0.00	0.00	0.00	363.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	22.71	2.13	0.71	0.00	0.35	1.42	0.00	3.55	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	17.23	2.65	0.99	0.33	1.33	0.33	0.00	2.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	62.08	4.19	9.23	2.52	0.84	0.84	0.00	12.58	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	40.87	4.13	2.30	2.30	0.46	0.00	0.00	4.13	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	21.39	2.59	0.32	0.32	1.30	1.94	0.00	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	16.38	2.25	0.32	1.28	0.00	1.93	0.00	2.57	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	34.58	5.34	0.63	0.63	1.26	0.00	0.31	2.51	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.10	1.41	0.00	1.41	1.41	0.71	0.00	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	16.82	3.93	0.00	0.00	2.24	0.56	0.00	2.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	57.32	5.57	0.80	1.59	1.59	0.80	0.00	15.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	22.42	3.74	1.02	0.68	1.36	0.34	0.00	4.76	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	14.62	1.30	0.65	0.32	1.30	1.30	0.00	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.49	2.48	1.06	0.35	1.06	1.42	0.00	2.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	323.28	16.16	48.49	0.00	16.16	0.00	0.00	323.28	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	221.13	31.59	0.00	7.90	23.69	7.90	0.00	213.23	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	16.09	0.98	0.49	0.49	0.49	1.46	0.00	1.46	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	17.85	2.48	2.48	0.00	1.49	0.50	0.00	3.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	16.42	0.94	0.94	0.00	0.94	0.47	0.00	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.85	1.66	0.33	0.66	0.33	1.32	0.00	1.32	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.99	0.31	0.00	0.31	2.47	0.31	0.00	0.93	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.54	0.61	0.00	0.61	0.92	0.61	0.00	2.14	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	35.48	0.95	0.79	0.32	1.58	0.48	0.32	1.43	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	39.63	0.64	1.28	0.80	0.96	0.16	0.00	0.32	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	38.42	1.02	1.78	0.51	0.64	0.51	0.25	0.76	0.00	0.13
Adipocyte - omental, donor2	11474-119C7	31.39	1.49	0.00	1.49	0.00	0.00	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	25.79	0.33	0.33	0.33	0.33	0.00	0.33	1.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	29.35	1.91	0.64	0.64	0.00	1.28	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	32.07	0.00	1.35	0.45	0.00	0.00	0.00	0.90	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	28.33	1.04	1.04	0.35	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	54.37	2.74	2.74	1.17	0.59	0.59	0.20	1.56	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	31.40	1.03	1.29	1.03	0.00	0.26	0.26	2.83	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	36.52	1.39	1.12	0.28	0.28	0.00	0.00	1.67	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	29.39	1.18	0.59	0.59	1.76	0.59	0.00	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	60.49	1.21	2.17	1.61	0.64	0.64	0.00	1.45	0.00	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	37.12	0.32	0.65	1.94	1.29	0.65	0.00	3.55	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	27.19	0.53	0.00	1.07	0.00	0.00	0.53	2.67	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	39.51	0.56	1.67	1.67	1.11	0.00	0.00	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	37.85	0.00	2.08	0.83	1.25	0.42	0.42	2.50	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	28.13	1.00	1.26	1.00	0.25	0.75	0.00	2.01	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	42.87	0.65	1.31	2.29	0.65	0.33	0.00	1.96	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	30.14	0.00	0.61	0.91	0.61	0.91	0.00	1.22	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	16.13	0.22	0.66	0.00	1.55	0.66	0.00	0.44	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	7.17	0.00	0.00	0.00	0.36	0.36	0.00	0.00	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	0.00	0.00	0.00	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	15.11	0.18	0.18	0.72	0.90	0.18	0.00	0.54	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	14.79	0.00	0.21	0.00	0.41	0.62	0.41	0.62	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	63.96	6.06	2.63	0.80	0.23	0.57	0.00	0.00	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	29.14	3.18	0.73	0.49	0.24	0.00	0.00	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	33.70	0.45	1.80	2.70	0.90	0.45	0.00	1.35	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	39.51	0.43	0.43	2.17	1.30	0.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	23.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	39.16	0.90	2.09	0.60	0.90	1.49	0.60	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	49.32	0.00	1.26	2.53	0.00	1.26	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	27.72	0.66	0.66	0.66	1.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	33.46	0.97	1.62	0.65	0.32	0.32	0.00	0.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	38.84	3.40	1.94	0.49	1.46	0.49	0.00	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	23.16	0.59	1.19	1.78	1.19	0.59	0.00	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	36.16	1.51	3.39	1.13	1.51	0.38	0.00	1.13	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	34.83	2.18	0.73	0.73	0.73	0.00	0.73	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	2.51	0.00	1.25	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	41.02	2.14	1.81	0.82	2.64	0.82	0.16	0.16	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	38.21	0.00	2.73	1.36	2.73	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	23.82	1.06	2.11	1.36	1.36	0.75	0.15	0.45	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	35.36	0.00	1.07	1.07	1.07	0.00	1.07	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	30.42	1.51	1.32	0.76	0.57	0.38	0.00	0.57	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	27.80	1.34	1.34	0.53	1.60	1.60	0.80	0.53	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	0.98	0.00	0.98	2.93	0.00	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	34.50	0.66	1.99	0.50	0.66	1.99	0.50	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	22.81	0.00	0.00	1.20	2.40	0.00	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	30.36	1.89	0.86	0.51	1.37	0.51	0.00	0.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	0.00	0.00	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	38.35	0.97	0.97	0.97	2.43	0.00	0.49	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.01	3.42	1.14	0.76	1.14	0.38	0.00	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	26.65	3.63	1.21	1.21	1.21	0.00	0.00	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	32.49	0.57	5.13	0.00	0.00	0.57	0.57	1.71	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	28.00	1.71	1.50	0.43	0.86	1.07	0.21	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	23.49	1.29	1.03	1.03	1.29	1.03	0.00	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	29.09	0.00	0.94	0.94	1.41	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.79	1.29	0.96	0.64	2.25	0.32	0.00	0.32	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.11	0.00	2.14	0.71	0.71	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	39.19	0.00	0.00	0.58	2.34	0.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	28.30	0.30	0.90	0.90	0.60	1.51	0.00	0.00	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	1.19	0.00	0.00	2.38	1.19	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	37.63	0.51	2.03	0.00	0.00	0.00	0.51	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	36.42	0.51	1.27	0.76	1.53	1.27	0.25	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	26.05	0.00	0.00	0.00	0.64	0.00	0.64	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	37.11	0.86	1.29	0.00	0.43	0.00	0.00	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.88	1.06	2.54	0.85	0.21	0.85	0.42	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	25.23	1.74	1.74	0.58	1.16	1.16	0.00	0.87	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	34.01	0.00	0.00	0.00	0.94	1.89	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	37.63	1.19	1.53	0.34	0.85	0.34	0.00	0.34	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	0.00	2.32	0.00	0.00	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	0.00	4.23	2.11	0.00	2.11	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	24.23	2.36	1.93	1.29	1.72	0.43	0.21	0.64	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	25.27	1.80	0.00	0.00	0.00	0.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	28.43	1.46	0.00	1.46	1.46	0.00	0.00	2.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	33.56	1.38	2.53	0.23	1.38	0.92	0.00	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	5.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	25.42	1.02	0.76	1.27	1.78	0.51	0.00	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	29.52	1.65	2.06	0.83	1.24	0.41	0.41	1.03	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	25.40	1.84	1.53	0.92	1.22	0.92	0.00	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	39.20	2.39	1.43	0.96	1.91	0.00	0.00	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	26.17	2.22	0.89	0.89	0.89	0.44	0.89	0.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	19.84	0.00	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	24.92	2.77	1.11	0.00	2.22	0.55	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	27.27	1.85	1.32	0.53	1.32	0.53	0.26	1.06	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	25.08	1.45	2.18	0.36	1.09	1.09	0.00	1.82	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	20.51	3.07	1.11	0.86	0.49	0.37	0.00	0.61	0.61	0.00
Astrocyte - cerebellum, donor2	11580-120F5	12.15	1.88	0.17	0.00	0.34	0.51	0.00	0.34	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	8.60	1.89	0.21	0.00	0.00	0.21	0.00	0.63	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	72.85	8.37	6.27	1.39	0.00	0.35	0.00	1.39	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	68.43	4.85	3.24	1.13	0.16	0.16	0.00	2.43	0.00	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	68.76	6.12	4.03	0.75	0.75	0.89	0.30	3.58	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	128.22	1.72	1.72	3.21	0.34	0.34	0.00	5.73	0.92	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	140.57	2.38	3.38	3.63	0.38	0.00	0.50	4.01	0.63	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	137.92	2.84	2.96	4.78	0.46	0.34	0.34	4.10	0.68	0.00
Basophils, donor1	12241-129G9	47.34	0.00	1.57	1.31	0.78	0.00	0.00	2.35	0.00	4.18
Basophils, donor2	12242-129H1	98.14	0.00	2.89	0.00	0.36	0.36	0.00	9.38	0.00	3.25
Basophils, donor3	12243-129H2	62.18	0.88	0.88	1.18	0.29	0.88	0.15	1.18	0.00	1.18
Bronchial Epithelial Cell, donor1	11511-119G8	13.15	0.00	0.00	0.86	0.65	0.22	0.00	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	5.49	0.00	0.00	0.00	0.00	0.91	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	23.85	0.00	0.00	0.63	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	20.59	0.42	0.42	0.00	0.00	0.42	0.00	0.21	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	19.57	0.23	0.00	0.46	0.23	0.23	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	31.67	0.36	0.90	0.18	1.08	0.36	0.00	0.18	0.72	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	84.92	12.68	5.26	3.19	0.00	0.10	0.00	3.19	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	110.16	5.59	1.40	2.56	0.23	0.00	0.00	9.55	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	60.12	11.83	2.24	1.60	0.64	0.00	0.00	4.16	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	196.50	10.34	0.00	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	97.50	0.56	2.25	1.13	0.00	0.56	0.00	2.82	0.00	1.69
CD14+ Monocytes, donor2	11305-117B9	96.51	0.37	1.30	0.74	0.19	0.56	0.00	8.72	0.00	1.11
CD14+ Monocytes, donor3	11381-118B4	92.64	0.44	0.00	1.10	0.88	0.00	0.00	9.44	0.00	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	67.36	0.28	2.26	2.26	1.13	0.85	0.00	3.68	0.00	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	65.58	0.38	2.27	0.38	2.27	1.52	0.00	3.41	0.00	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	66.41	0.99	0.99	1.31	1.64	0.33	0.33	1.97	0.00	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	80.37	0.72	2.17	1.88	1.59	0.43	0.00	8.24	0.00	3.76
CD14+ monocytes - mock treated, donor2	11873-125C1	66.99	0.00	2.11	1.21	1.51	1.21	0.00	3.32	0.00	4.22
CD14+ monocytes - mock treated, donor3	11883-125D2	90.02	0.71	2.13	2.37	1.18	1.18	0.24	6.16	0.00	4.03
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	53.90	0.33	1.34	1.34	0.84	0.84	0.50	6.03	0.00	5.36
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	52.44	0.00	1.93	1.66	0.28	0.28	0.28	5.52	0.00	7.73
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	72.89	0.74	1.24	1.24	0.50	0.74	0.99	3.22	0.00	9.42
CD14+ monocytes - treated with BCG, donor1	11860-125A6	50.12	0.00	0.59	1.37	0.59	0.78	0.00	3.33	0.00	3.72
CD14+ monocytes - treated with BCG, donor2	11870-125B7	55.55	1.07	2.14	1.07	1.42	0.53	0.18	3.74	0.00	3.92
CD14+ monocytes - treated with BCG, donor3	11880-125C8	73.34	0.65	1.52	2.61	0.65	1.52	0.22	3.26	0.00	8.27
CD14+ monocytes - treated with Candida, donor1	11868-125B5	46.59	0.00	0.70	1.40	0.23	0.47	0.47	3.51	0.00	4.45
CD14+ monocytes - treated with Candida, donor2	11878-125C6	79.20	0.53	0.53	1.06	0.53	1.06	0.00	3.70	0.00	19.01
CD14+ monocytes - treated with Candida, donor3	11888-125D7	74.33	0.00	0.00	3.33	1.11	1.11	0.00	1.11	0.00	11.09
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	75.56	0.30	2.23	1.64	0.74	0.45	0.00	6.99	0.00	4.91
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	64.65	0.20	1.40	2.20	1.40	0.60	0.80	2.99	0.00	3.59
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	94.73	0.62	4.58	1.25	1.87	1.25	0.83	3.12	0.00	7.70
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	59.26	0.23	2.52	0.46	0.69	0.92	0.00	3.20	0.00	6.41
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	63.56	0.00	2.04	1.36	1.36	0.00	0.45	1.81	0.00	5.43
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	61.10	0.44	1.31	0.44	0.87	0.00	0.00	1.75	0.00	4.80
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	68.32	0.27	0.81	2.15	0.54	0.54	0.00	4.57	0.00	3.23
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	73.27	0.52	1.92	2.27	1.40	0.52	0.00	4.54	0.00	2.44
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	85.85	0.84	1.68	1.26	1.68	0.00	0.42	6.31	0.00	6.31
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	57.13	0.37	0.73	1.29	1.10	0.37	0.00	4.96	0.00	2.57
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	52.84	0.00	0.35	1.41	0.35	0.00	0.70	3.17	0.00	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	68.00	0.00	0.88	2.19	0.44	1.32	0.44	1.75	0.00	4.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	49.17	0.35	1.57	1.22	1.57	1.92	0.70	5.75	0.00	8.54
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	57.61	0.00	1.86	1.12	2.60	0.74	0.00	6.69	0.00	7.06
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	79.97	0.43	1.72	2.16	1.51	2.59	0.86	4.96	0.00	13.80
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	62.65	0.41	1.64	0.41	0.41	1.23	0.00	2.05	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	54.01	0.46	1.39	1.62	0.70	0.46	0.00	2.09	0.00	2.55
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	62.41	0.23	0.93	1.16	0.00	0.70	0.23	3.25	0.00	2.55
CD14+CD16+ Monocytes, donor1	11789-124B7	76.72	1.09	2.62	1.53	0.00	0.65	0.00	2.83	0.00	2.83
CD14+CD16+ Monocytes, donor2	11801-124D1	81.08	1.39	0.92	1.85	0.92	0.00	0.00	3.46	0.00	2.08
CD14+CD16+ Monocytes, donor3	11912-125G4	88.60	1.52	2.17	0.65	0.22	0.87	0.00	4.77	0.00	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	112.28	0.47	1.87	1.25	1.25	0.31	0.00	6.70	0.00	1.87
CD14+CD16- Monocytes, donor2	11799-124C8	94.48	0.35	1.57	1.92	0.87	0.17	0.35	4.89	0.00	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	136.68	0.45	1.11	1.11	1.34	0.00	0.00	8.70	0.00	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	80.12	0.00	1.02	0.51	0.26	0.51	0.00	4.85	0.00	2.30
CD14-CD16+ Monocytes, donor2	11800-124C9	77.29	0.88	0.44	0.66	0.66	0.22	0.00	4.61	0.00	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	80.64	0.00	1.05	1.26	0.63	0.00	0.00	5.05	0.00	1.26
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	52.84	0.00	0.00	2.03	0.00	0.00	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	93.56	4.07	1.36	1.36	0.68	0.00	0.00	3.39	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	98.38	2.07	1.04	2.07	0.00	0.00	0.00	5.18	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	112.47	1.60	1.60	2.67	0.53	0.00	0.00	3.20	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	119.54	3.75	2.14	1.61	0.00	0.00	0.00	1.61	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	102.48	2.81	1.40	0.70	0.00	0.00	0.00	4.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	84.71	5.49	0.78	0.00	0.00	0.78	0.00	5.49	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	89.64	3.95	0.00	0.00	0.00	0.00	0.00	7.91	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	96.98	0.00	2.47	0.82	0.00	0.00	0.00	9.86	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	78.35	0.73	2.18	1.45	0.00	0.00	0.00	16.68	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	93.39	1.01	1.01	2.52	0.00	0.00	0.00	11.11	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	100.21	0.00	3.23	2.02	0.81	1.21	0.40	4.44	7.68	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	66.71	0.40	0.80	3.99	0.80	0.80	0.00	4.79	4.39	0.00
CD34+ Progenitors, donor1	11545-120B6	85.34	9.04	7.03	1.00	0.00	0.00	0.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	97.75	8.99	2.25	2.25	0.00	0.56	0.00	1.12	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	66.51	12.78	1.88	1.50	0.75	0.00	0.00	4.13	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	71.03	9.02	2.93	1.13	0.23	0.23	0.00	2.71	2.71	0.00
CD4+ T Cells, donor1	11225-116C1	135.68	0.71	2.86	1.79	0.36	0.36	0.00	23.92	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	99.20	1.22	4.90	0.00	0.00	0.00	0.00	27.56	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	85.70	0.30	1.52	1.83	0.30	0.00	0.00	11.89	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	85.25	0.51	1.02	1.02	0.00	0.00	0.00	2.04	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	85.57	1.35	0.67	0.45	0.22	0.00	0.22	4.72	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	75.89	0.29	0.29	1.72	0.29	0.00	0.00	5.46	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	102.40	1.90	2.84	2.84	0.00	0.00	0.00	2.84	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	108.86	2.11	2.11	2.81	0.00	0.00	0.70	5.62	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	131.85	3.30	3.30	0.00	0.00	0.00	0.00	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	70.09	1.30	1.01	1.59	0.14	0.29	0.00	2.46	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	60.50	0.68	0.85	1.69	0.34	0.00	0.00	4.41	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	57.07	0.81	0.81	0.97	0.32	0.16	0.16	5.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	81.14	0.45	2.24	0.90	0.00	0.00	0.00	13.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	78.26	0.70	0.70	1.40	0.00	0.00	0.00	6.29	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	99.88	1.32	2.20	1.76	0.44	0.00	0.00	8.80	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	92.34	0.42	2.11	3.37	0.42	0.42	0.00	5.06	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	58.80	0.00	0.62	1.66	0.00	0.00	0.00	6.23	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	51.79	0.67	1.00	1.34	0.00	0.00	0.33	8.35	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	90.01	0.27	1.63	1.63	0.27	0.27	0.00	8.70	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	119.52	0.54	2.14	2.68	1.07	0.00	0.00	8.58	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	109.39	0.00	1.79	1.79	0.00	0.00	0.00	12.55	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	95.87	0.37	0.56	0.93	0.37	0.00	0.00	5.19	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	66.93	0.22	0.65	1.08	0.22	0.00	0.00	4.77	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	63.89	0.00	0.00	1.26	0.21	0.21	0.42	4.83	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	88.48	1.01	2.02	2.53	0.00	0.51	0.51	4.04	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	83.62	1.30	1.73	0.00	0.00	0.00	0.00	4.77	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	101.98	0.44	2.18	1.31	0.44	0.00	0.00	6.97	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	113.82	3.46	0.99	1.98	0.00	0.00	0.49	4.45	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	96.01	3.69	0.92	0.00	0.00	0.00	0.00	4.62	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	117.25	4.19	2.79	2.79	0.00	0.00	0.00	4.19	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	119.91	3.32	1.66	2.22	0.28	0.55	0.00	1.66	0.00	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	121.71	3.93	0.98	0.74	0.25	0.25	0.00	3.44	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	112.42	3.08	1.54	1.54	0.00	0.00	1.54	7.70	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	119.61	0.72	3.22	2.51	1.07	0.00	0.00	7.88	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	142.65	0.00	0.00	1.38	0.00	0.00	0.00	8.31	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	89.38	0.65	2.62	1.31	0.00	0.00	0.00	10.15	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	76.96	0.75	3.75	1.50	0.00	0.00	0.38	15.39	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	98.22	2.78	2.02	0.25	0.00	0.00	0.00	19.19	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	52.07	5.28	0.69	1.84	0.46	0.46	0.46	1.61	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	51.52	2.88	0.96	1.68	0.24	0.72	0.00	2.64	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	53.62	2.74	1.64	3.01	0.55	0.27	0.27	1.09	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	60.34	2.70	1.50	1.50	0.00	0.00	0.00	2.70	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	40.56	3.12	0.96	1.68	0.72	0.24	0.72	2.16	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	43.89	3.41	0.91	1.59	0.23	0.23	0.00	1.82	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	56.71	3.48	0.65	1.09	0.22	0.43	0.22	1.09	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	49.75	2.63	0.79	1.84	0.00	0.00	0.00	2.90	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	53.70	2.81	0.23	1.88	0.23	0.00	0.47	0.47	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	48.60	5.43	0.91	1.21	0.60	0.00	0.30	2.42	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	46.19	5.52	0.29	1.45	0.29	0.00	0.00	1.45	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	63.68	4.80	0.53	0.53	0.53	0.27	0.27	2.13	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	47.71	1.31	0.88	0.88	0.00	0.00	0.44	0.44	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	54.65	3.64	0.46	1.37	0.46	0.00	1.37	1.37	0.46	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	37.29	2.98	1.49	0.75	0.00	0.00	0.00	2.24	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	48.98	2.52	1.08	2.52	1.08	0.00	0.36	2.16	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	47.76	3.74	1.15	2.30	0.00	0.00	0.00	2.88	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	51.85	2.12	0.71	1.41	0.47	0.00	0.24	1.89	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	64.65	4.44	0.95	0.63	0.63	0.32	0.00	2.54	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	59.97	3.08	1.54	1.85	0.62	0.62	0.31	1.54	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	60.27	3.53	0.96	2.24	0.32	0.64	0.32	0.96	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	58.52	2.29	1.53	3.06	0.00	0.00	0.00	2.29	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	57.93	3.55	0.39	0.79	0.00	0.00	0.00	1.58	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	42.36	3.78	1.51	3.03	0.00	0.00	0.00	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	75.48	2.41	1.61	3.21	0.00	0.00	0.00	5.62	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	69.24	4.90	1.40	1.40	0.00	0.00	0.70	4.20	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	87.15	5.01	1.00	1.00	0.00	0.00	1.00	3.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	36.55	0.00	0.00	0.00	3.66	3.66	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	35.57	0.99	0.99	0.49	0.49	0.99	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	32.83	1.05	1.89	0.32	0.32	0.21	0.11	0.00	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	44.72	4.51	1.39	1.04	0.35	0.00	0.69	2.08	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	30.21	1.07	1.42	1.07	0.36	0.71	0.00	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	38.00	1.82	1.82	0.23	0.91	0.23	0.00	1.59	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	102.95	3.58	3.58	1.79	1.79	0.00	1.79	1.79	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	39.63	0.81	0.40	0.40	0.00	0.00	0.00	2.43	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	71.38	9.75	4.13	1.03	1.26	1.49	0.11	3.10	1.84	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	40.40	5.56	2.35	0.43	1.50	0.86	0.21	1.71	2.57	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	49.12	6.90	2.12	1.15	0.62	0.97	0.27	1.95	0.88	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	44.66	3.03	4.40	1.10	1.83	1.01	0.18	6.33	0.46	0.09
Corneal Epithelial Cells, donor1	11526-119I5	9.00	0.00	0.22	0.22	1.54	0.22	0.22	0.00	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	13.65	0.00	0.00	0.00	0.00	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	16.62	0.00	1.02	0.26	0.51	0.77	0.00	0.00	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	49.20	0.17	2.81	0.83	3.96	1.49	0.17	0.50	0.00	2.15
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	60.24	0.32	1.58	0.32	0.95	1.89	0.63	1.89	0.00	2.21
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	72.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	44.60	0.65	2.38	0.86	2.38	1.08	0.22	1.51	0.22	2.59
Dendritic Cells - plasmacytoid, donor1	11228-116C4	115.47	9.57	2.73	0.68	0.00	0.68	0.00	10.25	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	103.81	9.79	2.61	1.31	0.00	0.00	0.00	0.65	0.00	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	115.18	12.10	2.90	0.48	0.00	0.00	0.48	1.94	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	24.52	1.00	1.00	0.67	0.67	0.67	0.33	0.50	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	17.02	1.76	0.59	1.76	0.59	0.59	0.59	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	25.73	0.85	0.85	0.85	1.13	0.28	0.00	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	23.59	1.18	0.39	1.18	0.79	0.00	0.39	0.00	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	18.33	0.29	0.29	0.00	0.87	0.87	0.58	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	46.35	1.88	1.65	1.41	1.88	1.18	0.24	0.24	0.24	0.24
Endothelial Cells - Artery, donor3	11413-118E9	30.68	1.05	0.70	0.70	1.05	0.35	0.35	0.35	0.53	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	48.54	0.89	1.33	1.99	1.55	0.89	0.22	2.44	0.44	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	52.64	1.22	2.43	0.91	1.22	0.91	1.22	3.35	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	53.84	3.38	1.13	1.41	1.41	0.00	0.28	1.41	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	37.14	0.59	0.89	0.59	1.19	0.59	0.30	0.59	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	22.39	1.56	2.08	0.52	0.00	0.52	0.00	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	23.39	1.70	1.13	0.57	0.99	0.43	0.85	0.71	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	58.02	2.00	2.00	2.40	0.80	1.20	0.80	1.60	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	28.83	1.05	0.52	1.05	0.00	0.00	0.52	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	95.17	4.35	1.62	2.86	2.36	0.99	0.50	4.47	0.50	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	48.88	2.17	0.22	1.74	1.52	1.09	1.09	2.61	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	65.09	2.08	1.22	1.59	1.34	1.34	1.47	1.10	0.37	0.00
Endothelial Cells - Vein, donor1	11267-116G7	19.34	2.28	0.00	0.00	0.00	2.28	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	20.26	1.40	2.79	0.00	0.70	0.70	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	33.60	0.94	0.31	0.47	0.79	0.63	0.47	0.31	0.31	0.00
Eosinophils, donor1	12244-129H3	76.23	0.00	0.00	0.00	0.00	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	97.37	0.00	1.65	3.30	0.00	0.00	0.00	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	42.80	0.00	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	9.04	0.00	0.49	0.00	0.00	0.49	0.00	0.24	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	16.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	37.36	1.23	1.64	0.41	2.05	0.41	0.00	2.46	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.04	0.22	1.42	0.88	1.20	1.20	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	23.08	1.84	1.95	0.22	1.08	0.76	0.00	0.22	0.11	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	56.76	2.79	4.12	0.97	1.58	1.94	0.36	0.85	0.12	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	56.77	0.82	3.55	1.77	1.09	0.55	0.14	5.87	0.27	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	32.48	1.37	2.00	0.95	0.95	0.84	0.21	0.74	0.00	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	51.91	1.84	2.90	0.79	0.26	0.53	0.26	5.27	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	56.81	1.33	1.99	1.00	0.66	1.00	0.33	0.66	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	20.41	1.81	0.45	1.36	0.00	0.00	0.45	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	17.43	0.00	0.76	1.52	0.00	0.76	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	21.92	1.26	0.79	0.32	1.10	0.63	0.16	0.95	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	53.04	3.94	3.64	0.61	0.91	1.82	0.30	0.91	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	45.81	2.16	2.28	1.02	0.38	1.27	0.25	1.52	0.38	0.13
Fibroblast - Cardiac, donor6	11460-119B2	41.99	1.97	1.52	1.97	0.30	0.76	0.15	1.06	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	17.55	4.15	1.88	1.21	0.27	0.27	0.13	0.80	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	23.73	3.88	1.73	0.00	0.43	1.29	0.86	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	45.41	4.39	4.39	2.93	0.00	0.00	0.00	1.46	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	23.53	4.38	1.61	0.46	0.23	0.23	0.00	0.92	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	56.31	7.97	2.04	0.51	1.02	0.34	0.17	1.02	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	32.63	0.94	2.11	0.23	0.94	0.94	0.00	0.70	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	34.43	0.00	0.47	0.00	0.00	0.47	0.00	0.94	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	35.90	1.45	2.06	0.60	0.60	0.97	0.00	0.48	0.85	0.00
Fibroblast - Dermal, donor4	11450-119A1	57.88	2.26	1.02	1.13	0.45	0.68	0.45	0.68	1.13	0.00
Fibroblast - Dermal, donor5	11454-119A5	54.95	2.62	1.22	1.22	0.35	0.52	0.17	1.05	1.22	0.00
Fibroblast - Dermal, donor6	11458-119A9	67.57	2.92	1.62	1.30	0.49	0.81	0.49	1.95	0.97	0.00
Fibroblast - Gingival, donor1	11237-116D4	62.68	2.08	3.12	1.04	1.04	0.83	0.83	0.83	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	42.71	0.52	3.14	0.26	0.52	1.83	0.00	1.83	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	47.97	2.64	1.32	1.71	0.79	0.53	0.00	3.56	0.26	0.00
Fibroblast - Gingival, donor3	11394-118C8	57.05	2.90	1.93	0.39	1.93	0.97	0.10	1.45	0.19	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	36.36	1.04	0.00	2.08	0.00	2.08	1.04	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	25.37	1.23	0.53	0.53	0.70	0.53	0.00	1.06	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	54.25	1.87	1.87	1.25	0.62	1.09	0.16	0.62	0.47	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	50.30	2.57	2.70	1.08	1.35	0.68	0.14	1.35	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	22.94	0.71	1.76	0.00	1.06	0.35	0.35	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	43.73	1.02	1.61	1.32	0.73	1.90	0.00	1.17	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	54.54	1.09	1.64	1.09	1.23	1.64	0.00	1.23	0.27	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	50.90	0.77	1.54	1.32	1.10	1.32	0.44	0.44	0.11	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	39.47	3.08	0.88	0.73	0.88	0.88	0.00	1.61	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	17.67	0.00	0.00	2.72	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	44.76	2.98	0.00	0.00	0.00	2.98	0.00	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	42.42	1.06	0.84	0.63	0.42	0.42	0.42	0.63	0.84	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	14.99	0.83	0.00	0.00	0.83	1.67	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.52	0.28	0.56	0.28	0.28	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	35.73	1.62	0.81	0.81	2.03	0.81	0.00	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	15.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	5.96	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	83.02	2.33	2.72	0.97	1.36	0.78	0.00	1.55	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	77.05	1.82	1.82	1.52	1.67	0.76	0.61	2.12	0.61	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	81.70	2.45	0.31	1.22	1.84	0.92	0.00	0.00	1.22	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	37.02	0.38	0.76	0.76	0.76	0.76	0.00	1.14	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	38.07	0.54	1.62	0.54	0.81	1.62	0.00	1.35	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	27.49	1.28	0.46	0.46	0.58	0.46	0.23	1.04	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	51.29	1.55	3.21	1.55	1.11	0.88	0.44	0.11	0.66	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	18.90	0.41	1.02	1.42	0.41	0.61	0.20	0.61	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	40.72	1.19	0.79	0.79	1.19	0.40	0.40	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	88.71	1.39	2.78	1.79	0.20	0.60	0.00	3.77	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	39.43	1.95	2.84	0.89	1.07	0.89	0.00	0.18	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	47.50	0.79	0.99	0.99	0.39	0.59	0.20	0.79	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	60.77	1.81	3.01	2.41	0.00	0.30	0.00	3.01	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	60.56	1.19	2.27	1.51	0.22	0.65	0.11	1.73	0.22	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	82.50	0.76	3.29	3.04	0.51	0.51	0.00	3.54	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	48.90	1.31	1.64	0.98	1.48	0.66	0.00	1.31	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	66.77	1.40	3.21	2.21	0.80	0.20	0.20	8.82	0.80	0.00
Fibroblast - skin normal, donor2	11561-120D4	55.86	1.51	1.51	1.11	0.30	1.31	0.20	1.21	0.50	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	82.81	2.42	1.51	2.42	0.30	0.30	0.00	3.63	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	54.60	1.08	1.99	1.16	0.58	0.83	0.08	1.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	53.85	1.88	0.34	0.34	0.17	0.85	0.17	2.74	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	56.16	1.64	1.97	1.97	0.33	0.00	0.00	3.28	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	60.08	0.85	1.92	0.75	1.17	0.85	0.21	0.85	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	51.62	2.53	0.67	0.67	0.84	0.84	0.00	1.35	1.35	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	45.01	1.25	2.35	0.63	1.57	0.63	0.16	0.16	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	576.15	44.32	44.32	0.00	0.00	0.00	0.00	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	74.95	0.00	3.49	0.87	0.87	0.00	0.00	6.97	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	45.42	0.17	1.21	0.35	4.16	1.04	0.00	0.00	0.87	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	49.19	0.00	1.56	0.26	2.08	1.04	0.52	0.78	2.60	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	38.84	0.00	2.56	0.77	2.04	2.04	0.51	0.77	1.02	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	48.23	4.59	3.83	0.00	0.77	0.00	0.00	3.06	7.66	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	58.70	15.95	4.47	1.28	0.00	0.00	0.00	1.91	15.31	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	53.06	22.25	5.99	0.29	0.86	0.57	0.29	5.71	25.39	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	50.46	8.00	3.58	0.28	0.55	0.00	0.00	8.00	3.58	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	59.14	16.90	3.42	2.05	0.23	0.00	0.00	6.85	1.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	52.11	15.45	4.16	1.19	0.40	0.59	0.40	4.56	13.47	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	40.44	7.14	2.91	0.79	0.26	0.53	0.53	6.34	3.44	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	55.12	21.53	2.94	1.63	0.98	0.65	0.00	6.85	1.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	49.53	26.98	5.31	1.33	2.65	0.00	0.00	7.96	28.30	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	48.61	11.31	9.33	0.99	0.28	0.00	0.00	2.54	14.56	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	39.77	5.30	6.03	1.11	0.62	0.00	0.00	1.85	6.77	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	38.95	10.21	5.64	1.07	0.27	0.00	0.00	2.42	15.85	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	40.76	4.83	2.48	1.12	0.12	0.12	0.00	1.24	8.80	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	45.68	5.68	3.74	0.42	0.14	0.14	0.00	1.80	13.43	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	35.17	8.74	3.25	0.61	0.20	0.20	0.00	2.44	18.91	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	30.80	6.16	3.65	0.91	0.23	0.23	0.23	0.23	6.62	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	39.74	5.23	2.62	0.50	0.50	0.25	0.00	1.62	7.47	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	37.16	4.37	3.28	0.66	0.66	0.00	0.00	0.87	5.90	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	33.98	3.55	2.66	0.00	0.59	0.30	0.00	0.00	2.36	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	44.67	5.40	3.18	0.79	0.32	0.16	0.00	1.91	4.77	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	32.17	4.02	3.80	0.89	0.45	0.00	0.00	1.34	2.23	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	41.74	5.85	1.01	1.81	0.40	0.20	0.00	1.61	1.41	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	53.61	5.77	3.05	1.19	0.51	0.51	0.00	1.36	2.71	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	56.22	9.93	4.88	1.06	0.71	0.09	0.00	1.60	6.83	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	53.59	7.60	1.87	1.04	0.10	0.10	0.00	1.56	1.14	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	39.96	6.66	1.37	1.20	0.51	0.00	0.17	0.85	0.85	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	48.25	4.54	2.55	1.22	0.44	0.11	0.00	0.44	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.83	7.74	4.16	0.83	0.58	0.42	0.00	1.58	4.91	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	48.80	7.35	3.06	1.23	0.41	0.00	0.00	1.84	4.49	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	42.50	7.22	0.83	0.83	0.41	0.21	0.21	1.65	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	43.93	4.27	1.73	0.69	0.35	0.12	0.00	2.08	1.27	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	44.53	5.50	2.67	1.33	0.50	0.17	0.00	1.33	1.83	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	32.62	3.97	1.54	0.66	0.66	0.22	0.44	2.42	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	44.65	5.78	2.71	0.98	0.74	0.12	0.00	2.21	1.84	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	45.55	5.35	1.95	1.13	0.97	0.32	0.00	2.92	1.62	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.28	3.85	0.32	0.64	0.64	0.00	0.32	0.96	1.92	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	40.74	4.36	1.52	0.38	0.47	0.28	0.09	0.85	1.14	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	31.79	3.48	1.27	0.32	0.32	0.47	0.16	1.74	1.27	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	37.40	4.26	0.00	1.82	0.30	0.30	0.00	0.61	1.82	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	47.36	5.54	1.57	0.73	0.31	0.31	0.21	1.46	1.67	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	27.44	3.29	2.20	0.44	0.22	0.00	0.00	1.76	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	32.82	3.93	2.24	0.84	1.12	0.56	0.00	1.12	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	44.90	2.69	2.50	1.30	0.83	0.37	0.19	0.74	0.93	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	37.17	4.01	1.87	1.34	0.53	0.80	0.00	1.34	4.81	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	40.09	2.45	1.99	0.92	0.92	0.77	0.61	0.46	2.75	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	48.32	2.85	1.81	1.04	0.65	0.39	0.39	0.52	1.81	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	37.41	1.36	1.08	0.81	1.08	1.36	0.00	0.81	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	41.85	5.53	0.92	0.74	0.74	0.55	0.18	1.11	0.92	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	32.90	4.82	1.54	0.44	0.66	1.10	0.00	1.32	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	39.67	2.98	1.98	0.99	0.00	0.00	0.00	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	40.50	2.64	1.06	0.66	0.92	0.13	0.00	1.58	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.08	2.22	1.82	1.01	0.40	0.00	0.00	1.01	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	56.42	8.64	2.80	0.51	0.51	0.00	0.00	0.76	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	72.06	30.85	11.94	1.79	0.00	0.60	0.20	1.39	21.30	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	45.14	7.40	8.47	0.15	0.31	0.15	0.00	2.00	12.94	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	67.51	13.30	9.82	0.82	0.00	0.00	0.00	1.43	15.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	30.67	14.71	5.95	0.94	0.31	0.00	0.00	1.25	10.64	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	33.62	17.80	8.48	0.57	0.57	0.00	0.00	1.41	9.89	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	41.51	17.53	7.38	1.84	0.00	0.00	0.00	3.69	5.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	54.45	22.27	9.90	4.95	0.00	0.00	0.00	0.00	17.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	54.93	15.09	9.28	1.16	0.00	0.00	0.00	0.77	17.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	32.09	12.84	1.60	1.60	1.60	0.00	0.00	3.21	22.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	39.99	10.43	10.43	1.74	0.00	0.00	0.00	8.69	19.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	46.87	12.37	4.56	1.63	0.00	0.00	0.33	0.98	17.25	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	54.36	17.30	7.00	1.24	0.00	0.41	0.41	3.71	18.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	10.00	0.00	0.00	0.00	0.00	0.00	16.66	16.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	44.74	13.98	5.31	0.84	0.28	0.00	0.00	4.19	11.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	51.97	11.11	6.86	0.98	0.65	0.65	0.00	2.61	9.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	41.10	15.94	1.68	1.68	0.00	0.00	0.00	7.55	5.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	49.62	12.72	4.45	0.95	0.00	0.64	0.00	2.23	8.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	40.42	16.64	5.09	0.34	0.34	0.68	0.00	1.36	12.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	39.67	18.79	6.26	0.00	0.00	0.00	0.00	2.09	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	61.28	12.03	4.58	1.72	0.00	0.57	0.00	0.57	6.87	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	35.22	7.40	2.37	0.30	0.00	0.00	0.00	1.48	4.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	57.60	18.64	3.39	1.69	0.00	0.00	0.00	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	57.57	19.47	4.14	1.66	1.24	0.00	0.00	1.66	3.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	54.31	12.20	4.14	0.92	0.00	0.23	0.46	2.99	5.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	15.81	5.27	0.00	0.00	0.00	0.00	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	52.66	11.15	4.23	0.38	0.00	0.38	0.00	1.54	3.08	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	33.90	11.08	0.65	0.65	0.33	0.33	0.00	4.89	2.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	29.43	13.38	2.68	0.00	0.00	0.00	0.00	0.67	2.68	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	47.39	11.17	1.93	0.39	0.00	0.00	0.00	3.47	3.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	55.80	13.01	7.87	0.00	0.00	0.00	0.00	7.53	5.14	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	9.94	0.00	0.00	0.00	0.00	0.00	7.45	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	33.50	6.13	0.47	1.42	0.00	0.00	0.00	7.55	2.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	28.36	9.66	1.81	0.00	0.00	0.00	0.00	6.03	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	38.15	12.21	0.51	0.51	0.00	0.51	0.00	2.54	3.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	44.27	11.57	3.99	0.40	0.00	0.00	0.00	3.59	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	39.96	11.35	1.48	0.99	0.00	0.00	0.00	6.91	1.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	29.51	8.26	1.18	1.18	0.00	1.18	0.00	5.90	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	33.26	11.67	2.33	0.58	0.00	0.00	0.00	6.42	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	32.92	8.78	1.76	0.44	0.00	0.44	0.00	5.27	1.76	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	36.45	9.32	3.39	0.85	0.00	0.00	0.00	5.93	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	23.88	5.97	1.19	0.60	0.00	0.00	0.00	9.55	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	31.06	12.13	3.40	0.49	0.97	0.97	0.00	1.94	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	1.14	0.00	0.00	1.14	1.14	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	29.94	2.49	0.42	0.00	2.08	2.08	0.42	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	19.12	1.12	1.12	1.12	0.00	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	35.20	4.76	1.90	0.63	0.32	0.63	0.00	0.95	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	26.32	3.34	2.09	0.42	0.84	0.42	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	72.87	0.70	1.62	1.62	2.20	0.58	0.35	1.74	0.12	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	80.35	0.68	2.19	2.03	4.22	1.01	0.51	2.36	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	77.35	0.91	2.05	1.37	2.96	0.68	0.46	0.46	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	78.27	0.44	1.75	1.86	1.97	1.09	0.22	0.66	0.11	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	80.81	1.29	1.72	2.36	1.50	1.29	0.21	0.21	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	75.13	0.65	1.72	2.37	1.29	0.65	0.22	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	67.25	0.37	1.87	2.74	2.37	1.37	0.25	1.00	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	72.22	1.20	1.54	1.89	1.89	1.20	0.00	0.69	0.34	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	75.93	0.32	2.24	2.24	1.28	1.60	0.00	0.64	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.19	1.12	0.00	1.12	0.00	1.12	0.00	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.49	0.00	0.00	0.43	0.43	0.43	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	0.00	2.64	2.64	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	13.40	0.00	0.00	0.35	1.41	0.00	0.35	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	8.72	0.73	0.73	1.45	1.45	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	36.19	0.87	3.15	0.17	0.70	0.70	0.17	0.35	0.87	0.00
Hepatocyte, donor1	11523-119I2	37.53	0.00	2.42	1.21	1.21	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	63.56	0.00	0.00	0.00	1.08	0.00	0.00	4.31	0.00	0.00
Hepatocyte, donor3	11684-122I1	52.76	0.61	0.00	0.61	2.45	1.23	0.61	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	86.15	10.44	2.61	1.96	0.00	0.00	0.00	6.53	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	76.73	3.50	5.59	0.87	1.75	0.35	0.17	5.42	4.54	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	44.04	6.45	2.74	0.55	0.82	1.10	0.00	0.82	1.51	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	26.70	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	27.08	0.00	0.00	0.00	0.00	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	0.00	1.38	0.00	0.00	0.00	0.00	0.00	8.31	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	0.00	2.50	0.00	0.00	0.00	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	0.00	0.00	0.00	0.00	0.00	2.56	0.00	7.69	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	29.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	12.99	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	0.00	0.00	1.67	0.00	0.00	0.00	0.00	8.34	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	35.73	1.32	1.32	0.00	0.00	0.00	0.00	0.00	17.21	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	25.50	0.00	3.33	0.00	0.00	1.11	0.00	0.00	9.98	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	10.48	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	23.93	0.00	0.00	1.26	1.89	0.00	0.00	0.00	13.86	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	0.00	1.55	1.55	0.00	0.00	0.00	0.00	7.73	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	29.27	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	27.78	0.00	0.00	0.65	0.00	0.00	0.00	0.00	12.27	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	12.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.66	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	29.34	0.00	0.81	0.00	0.00	0.00	0.00	0.81	11.41	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	23.51	0.42	0.84	0.42	0.42	0.42	0.00	0.00	11.33	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	14.37	0.00	0.00	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	32.15	0.00	0.00	1.61	0.00	0.00	0.00	0.00	13.66	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	20.31	0.92	0.92	0.00	0.00	0.00	0.00	0.00	13.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	27.85	0.00	0.47	0.47	0.00	0.00	0.47	0.00	11.80	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	16.33	1.81	0.00	0.00	0.00	0.00	0.00	0.91	12.70	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	14.74	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	23.67	0.00	2.15	2.15	1.08	0.00	0.00	0.00	6.46	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	22.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.62	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	23.59	0.00	0.00	0.64	0.00	0.00	0.00	0.64	12.12	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	40.10	0.00	1.82	0.00	0.00	0.00	0.00	0.00	10.94	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	21.42	0.71	0.00	0.00	0.00	0.00	0.71	0.00	10.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	13.27	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	32.10	0.31	0.93	0.62	0.62	0.00	0.00	0.62	12.66	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	0.00	0.00	0.00	0.00	1.76	0.00	0.00	5.27	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	0.00	3.14	3.14	3.14	0.00	0.00	0.00	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	20.17	0.70	0.00	2.09	0.00	0.70	0.00	0.00	20.17	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	0.00	2.21	0.00	2.21	0.00	0.00	0.00	11.07	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	35.66	3.24	0.00	0.00	0.00	0.00	0.00	0.00	12.97	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	17.44	0.87	0.00	0.00	0.00	0.00	0.00	0.00	8.72	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	0.00	2.25	0.00	0.00	0.00	0.00	0.00	6.75	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	0.00	3.48	0.00	0.00	0.00	0.00	0.00	10.45	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	20.27	0.00	1.07	1.07	0.00	0.00	0.00	1.07	6.40	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	18.01	1.39	1.39	0.00	0.00	0.00	0.00	0.00	11.08	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	2.85	0.00	0.00	0.00	0.00	0.00	0.00	11.40	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	19.33	0.92	0.00	0.92	0.00	0.00	0.00	0.00	11.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.13	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	23.26	2.11	1.06	0.00	1.06	0.00	0.00	0.00	6.34	0.00
Keratinocyte - epidermal, donor1	11272-116H3	43.17	1.31	3.84	1.22	1.14	0.65	0.08	0.41	5.79	0.08
Keratinocyte - epidermal, donor2	11349-117G8	14.06	0.59	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	53.10	0.47	2.27	0.95	1.23	0.66	0.09	1.04	0.76	0.00
Keratinocyte - oral, donor1	11251-116E9	72.20	0.79	4.20	1.02	1.25	1.14	0.11	1.70	1.02	0.11
Keratocytes, donor1	11527-119I6	22.01	1.03	1.38	0.34	0.34	0.69	0.34	0.69	0.69	0.00
Keratocytes, donor2	11607-120I5	10.55	2.34	1.17	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	28.06	1.38	0.40	0.99	0.00	0.20	0.00	0.20	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	50.55	0.00	0.00	6.59	0.00	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	35.60	2.16	0.00	0.00	2.16	0.00	0.00	1.08	4.31	0.00
Lens Epithelial Cells, donor2	11609-120I7	52.71	8.77	4.15	0.81	0.69	0.35	0.12	2.19	0.46	0.00
Lens Epithelial Cells, donor3	11690-122I7	36.23	4.54	3.94	0.61	1.31	0.91	0.20	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	34.62	2.37	1.90	1.07	0.83	0.24	0.24	1.19	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	29.02	0.00	1.67	0.56	0.28	0.28	0.00	1.67	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	43.45	1.10	0.94	1.10	1.26	1.42	0.31	1.42	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	27.96	1.08	0.54	0.00	1.08	0.00	0.00	1.61	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	26.79	0.00	0.63	0.32	0.00	0.63	1.26	1.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	20.59	0.75	0.65	0.65	0.75	0.32	0.32	0.75	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	36.11	0.82	0.82	0.82	0.00	0.00	0.41	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.18	0.00	0.76	0.76	0.76	0.25	0.00	1.01	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	24.77	0.84	0.70	0.14	0.42	0.42	0.00	1.27	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	28.48	0.79	1.19	0.40	1.98	0.40	0.40	2.77	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	33.54	1.16	0.58	0.97	0.78	1.16	0.19	1.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	13.89	0.93	0.00	0.19	0.19	0.19	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	34.15	0.35	0.70	0.35	0.00	1.74	0.35	2.09	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	28.38	0.48	0.24	0.72	1.43	0.24	0.00	0.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	19.23	0.82	0.82	0.82	0.14	0.55	0.55	0.69	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	27.72	1.85	1.54	0.31	0.92	0.62	0.00	1.85	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	19.02	0.31	0.62	1.25	0.31	0.31	0.00	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	26.72	0.55	0.55	0.37	0.18	0.55	0.37	1.46	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	31.27	0.99	0.66	1.32	0.33	0.33	0.00	0.99	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.64	0.29	1.17	0.29	0.29	0.59	0.29	1.17	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	17.43	0.75	0.25	0.50	0.50	0.75	0.00	1.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	36.37	0.48	0.00	0.97	0.00	0.48	0.48	2.91	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	25.85	0.00	1.08	0.27	1.35	0.27	0.27	0.81	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	28.31	0.45	0.61	0.61	1.06	0.91	0.15	1.82	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	24.88	0.00	0.52	1.04	1.04	0.00	0.00	1.04	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	29.31	0.21	1.05	1.26	0.63	0.84	0.21	2.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	20.60	0.75	0.75	0.45	0.60	0.15	0.15	1.20	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	29.58	1.38	1.38	0.00	3.44	0.00	2.06	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	28.41	1.13	0.56	0.94	0.75	0.00	0.56	0.56	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	17.81	1.38	0.42	0.32	0.64	0.21	0.21	0.32	0.53	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	29.56	0.97	0.00	0.97	1.45	0.97	0.48	1.94	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	22.49	0.00	1.32	0.33	0.99	0.33	0.00	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	17.34	0.74	0.50	0.99	0.50	0.37	0.12	1.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	47.02	1.48	0.37	1.48	1.48	0.00	1.11	2.22	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	23.23	0.74	1.24	0.00	0.99	0.74	0.25	2.22	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	17.46	0.82	0.41	0.41	0.27	0.27	0.14	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	31.52	0.96	0.32	1.61	0.96	0.32	0.00	2.25	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	30.43	1.22	1.52	1.52	0.61	1.52	0.00	1.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	33.03	1.68	1.40	0.56	1.40	0.98	0.56	1.26	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	31.29	1.42	1.07	0.71	0.71	0.36	0.71	0.71	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	14.54	0.97	0.00	0.00	0.00	0.00	0.48	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	13.54	1.09	0.78	0.93	0.31	0.31	0.16	0.47	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	23.99	0.36	0.36	1.07	2.15	0.36	0.72	0.72	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	19.93	0.00	0.33	0.33	0.65	0.00	0.65	1.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.89	0.47	0.24	0.24	0.71	0.47	0.24	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	35.15	0.99	0.87	1.11	1.11	0.99	0.37	0.62	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	15.88	0.26	0.51	0.26	0.26	0.26	0.00	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	19.39	1.19	0.30	0.00	0.60	0.60	0.60	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	0.00	0.00	0.00	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	17.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.88	0.00	1.48	0.00	0.00	0.00	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	16.08	0.00	1.69	0.42	0.42	0.00	0.00	1.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.14	0.00	0.00	0.00	1.41	0.70	0.00	4.22	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	16.81	0.00	0.93	0.00	0.93	0.00	0.00	1.87	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	13.91	0.00	0.52	0.52	0.00	1.03	0.00	0.52	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	14.48	0.23	0.00	0.23	0.00	0.23	0.23	0.00	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	27.05	0.29	1.16	0.87	0.00	0.00	0.00	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	24.31	0.00	0.90	0.45	0.45	0.45	0.00	1.80	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	21.68	0.27	0.54	0.54	0.54	0.41	0.00	0.54	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	16.43	0.51	0.00	0.51	0.00	0.00	0.00	2.05	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	21.88	0.00	1.76	1.41	0.35	0.00	0.35	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	21.99	0.00	3.33	0.67	0.67	0.00	0.00	1.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	17.83	0.00	3.06	0.51	2.04	0.00	0.00	3.57	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	25.88	0.53	0.53	0.27	0.27	1.07	0.00	1.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	27.21	0.57	1.51	0.57	1.13	0.19	0.00	1.70	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	14.73	0.00	0.61	0.61	0.00	0.61	0.00	1.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	23.65	0.00	0.82	0.82	0.00	0.82	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	23.53	0.21	1.67	0.21	0.83	0.83	0.00	2.50	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	23.82	0.28	1.96	0.28	0.56	1.12	0.00	2.80	0.56	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	17.52	0.00	2.06	0.00	1.03	0.00	0.00	3.09	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.39	0.58	1.45	0.29	0.29	0.29	0.00	1.45	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	23.02	0.30	1.20	0.90	0.60	0.30	0.00	3.59	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	27.11	1.11	0.55	0.55	0.00	0.00	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	24.74	0.00	1.06	1.06	0.00	0.71	0.35	2.47	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.18	0.00	0.74	1.11	1.11	0.37	0.00	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	11.51	0.00	0.00	0.00	0.00	1.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	20.34	0.38	1.54	0.00	0.00	0.77	0.00	0.77	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	20.38	0.57	1.70	0.57	2.83	0.57	0.57	2.26	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	21.33	0.00	0.82	0.00	0.82	0.00	0.00	2.46	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	15.82	1.36	1.36	0.45	1.36	0.00	0.00	1.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.21	0.00	0.00	0.00	1.44	0.00	0.72	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	27.64	0.00	1.49	0.75	0.75	0.00	0.00	3.73	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	17.46	0.37	0.74	0.74	0.37	0.37	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	15.08	0.43	0.43	1.29	1.29	0.86	0.00	3.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	15.41	0.00	1.71	0.00	0.00	0.00	0.00	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	21.99	0.67	1.00	0.67	0.00	0.67	0.33	1.33	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	19.31	1.21	1.81	1.21	0.60	0.00	0.00	1.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	16.35	0.00	0.71	1.42	0.71	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	13.40	0.00	0.34	0.00	0.69	0.69	0.00	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	19.86	0.54	1.07	0.00	1.07	0.54	0.00	3.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	18.18	0.00	0.00	2.02	0.67	0.00	0.00	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	17.78	0.37	1.11	0.00	0.00	0.37	0.37	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	2.33	0.00	0.00	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	32.41	0.40	0.80	0.80	1.20	0.80	0.00	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.90	0.73	0.00	0.00	0.73	0.73	0.00	1.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.03	0.77	1.53	1.53	0.00	0.77	0.00	3.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	18.74	0.00	1.48	0.49	0.99	0.00	0.00	1.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	21.64	0.00	1.88	0.00	0.94	0.00	0.00	5.65	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	14.58	0.50	0.00	0.00	1.01	0.00	0.00	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	18.48	0.45	0.45	0.90	0.45	0.45	0.00	3.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	1.72	0.00	0.00	1.72	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	18.26	0.89	0.45	2.23	0.45	0.00	0.00	1.78	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	21.90	0.00	0.78	0.00	0.00	0.00	0.00	1.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.15	0.00	1.32	0.66	0.00	0.00	0.00	1.98	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	15.05	0.00	1.04	0.52	1.04	0.00	0.00	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	20.57	0.00	1.31	0.00	0.00	0.00	0.00	1.31	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.89	1.12	0.56	0.56	0.56	0.00	0.00	1.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.11	0.00	0.44	0.44	0.44	0.44	0.00	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	22.76	0.77	2.70	1.16	0.00	0.77	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	19.75	0.00	1.01	0.00	0.51	0.00	0.00	1.01	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	19.22	0.48	1.44	0.00	0.96	0.00	0.00	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	20.67	0.40	1.59	0.80	0.00	0.00	0.00	2.39	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	15.80	1.22	1.22	0.00	0.00	0.61	0.00	3.65	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.83	0.00	0.69	1.38	0.00	0.00	0.00	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	21.66	0.00	1.14	0.38	0.76	0.00	0.00	2.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	14.46	0.00	1.03	0.00	0.52	0.52	0.00	2.58	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	11.49	0.00	0.60	1.21	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	28.52	0.00	1.58	0.95	1.58	0.32	0.00	1.27	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	15.46	1.60	1.07	0.00	0.53	1.07	0.00	3.20	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	11.49	0.00	0.57	1.15	0.57	0.00	0.00	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.60	0.00	0.00	0.00	0.00	0.00	0.51	1.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	14.85	0.00	0.71	0.00	0.00	0.00	0.00	3.54	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	18.73	0.00	0.00	1.13	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	24.96	0.00	1.25	0.00	0.00	0.42	0.00	2.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	17.23	0.00	2.35	1.57	0.78	0.00	0.00	2.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	15.03	0.00	0.00	0.42	0.42	0.00	0.00	1.25	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	15.33	0.00	1.86	0.00	0.93	0.00	0.00	2.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.73	0.00	1.34	0.67	0.00	0.67	0.00	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	14.97	1.07	1.07	1.60	0.53	0.53	0.00	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	19.80	0.00	0.81	0.40	0.40	0.40	0.00	1.21	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	16.52	0.00	0.00	0.00	0.92	0.00	0.00	1.84	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.89	0.00	0.00	0.00	0.00	0.89	0.00	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	16.53	1.14	1.14	1.14	0.57	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.87	0.77	0.00	0.77	0.00	0.00	0.00	3.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	16.42	0.00	1.09	0.55	0.00	1.09	0.00	1.64	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	20.05	0.00	0.00	0.45	0.00	0.45	0.00	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	20.02	0.52	0.52	0.52	0.00	0.26	0.26	0.78	1.04	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.94	0.00	0.00	0.00	0.66	0.66	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	2.08	2.08	2.08	0.00	2.08	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	57.89	0.46	3.19	0.91	1.37	1.37	0.23	1.82	0.23	2.05
Macrophage - monocyte derived, donor2	11313-117C8	33.95	0.92	1.65	0.18	2.02	1.47	0.18	1.84	0.18	2.20
Macrophage - monocyte derived, donor3	11389-118C3	38.67	0.26	1.18	0.92	1.57	1.57	0.13	2.10	0.39	2.23
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	52.04	0.53	4.25	2.12	1.06	1.06	0.53	0.53	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	55.30	0.95	2.22	0.95	1.90	1.11	0.16	0.95	1.90	0.16
Mallassez-derived cells, donor3	11930-125I4	53.93	0.56	3.61	1.95	2.36	0.28	0.28	2.36	5.98	0.14
Mammary Epithelial Cell, donor1	11273-116H4	69.15	1.89	7.27	1.20	1.69	1.59	0.20	1.49	0.70	0.00
Mammary Epithelial Cell, donor2	11350-117G9	52.70	1.45	3.19	1.74	2.32	0.58	0.00	0.29	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	17.46	0.25	0.75	0.25	0.00	0.50	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	140.33	10.17	16.27	6.78	0.68	0.00	1.36	2.03	0.68	6.78
Mast cell, donor1	11563-120D6	80.24	5.08	3.89	1.84	0.32	0.43	0.32	3.78	0.00	1.19
Mast cell, donor2	11565-120D8	120.65	5.05	3.27	2.67	0.00	0.30	0.59	2.08	0.00	0.59
Mast cell, donor3	11566-120D9	127.65	2.03	4.05	2.03	0.23	0.45	0.68	5.63	0.00	1.35
Mast cell, donor4	11567-120E1	108.32	3.01	3.01	2.66	0.53	0.53	1.60	4.79	0.00	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	82.17	2.99	2.55	1.77	0.55	0.22	0.22	5.99	0.00	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	62.45	4.67	2.33	2.33	1.75	0.00	0.58	9.34	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	78.24	2.87	2.75	1.61	0.11	0.11	0.11	3.33	0.11	1.38
Mast cell, expanded, donor8	11941-126A6	77.66	3.01	1.84	0.84	0.33	0.17	0.33	3.68	0.00	1.00
Melanocyte - dark, donor1	11502-119F8	47.06	3.58	1.29	0.80	1.19	0.60	0.70	0.30	0.50	0.00
Melanocyte - dark, donor2	11582-120F7	34.26	3.46	0.69	2.08	1.73	0.69	0.69	1.38	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	58.82	1.81	1.30	1.52	1.09	0.65	0.14	1.09	1.16	0.07
Melanocyte - light, donor1	11274-116H5	15.51	0.47	0.24	0.00	0.94	0.47	0.00	0.47	0.00	0.00
Melanocyte - light, donor2	11351-117H1	11.60	0.68	1.36	0.00	0.00	0.68	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	19.08	0.00	0.00	0.87	0.00	0.00	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	45.50	0.94	0.31	0.94	0.62	0.52	0.42	1.15	0.31	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	42.49	1.61	0.81	0.81	1.88	1.08	0.00	0.27	4.30	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	36.70	1.34	0.80	0.00	0.54	0.00	0.54	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	33.99	6.45	1.36	1.36	0.87	1.36	0.62	0.99	0.50	0.00
Meningeal Cells, donor2	11573-120E7	25.97	4.40	0.88	0.88	0.44	0.44	0.88	0.88	0.44	0.00
Meningeal Cells, donor3	11654-122E7	66.26	12.71	3.91	2.45	1.30	1.79	0.90	0.90	1.71	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	60.17	3.71	2.85	0.29	0.57	0.29	0.00	0.00	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	33.61	1.61	1.11	0.70	1.11	0.81	0.10	1.11	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	0.00	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	0.00	0.00	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	40.90	1.44	0.00	1.44	0.72	0.72	0.00	0.00	2.15	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	35.79	1.06	1.06	1.06	1.48	0.21	0.21	0.42	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	32.17	0.50	0.00	0.50	3.52	0.50	0.00	2.51	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	18.46	1.10	1.32	0.00	0.66	0.22	0.22	0.66	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.88	0.00	0.73	0.00	0.73	0.73	0.73	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	12.89	0.41	0.61	0.41	0.41	0.41	0.00	0.82	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	57.90	3.32	2.22	0.83	0.42	0.14	0.00	0.00	0.69	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	11.90	0.74	0.00	0.74	0.00	0.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	45.13	1.18	1.58	0.66	0.79	0.79	0.00	0.66	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.65	1.78	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	13.45	0.64	1.28	0.64	0.00	0.00	0.00	1.28	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	66.28	1.06	1.06	0.71	1.06	1.06	0.35	0.71	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	50.97	0.63	0.63	0.94	0.94	0.31	0.00	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	44.99	2.18	0.00	0.00	1.45	0.00	0.00	0.00	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	34.47	1.06	2.92	1.59	3.18	3.45	0.27	1.33	1.06	0.00
Mesothelial Cells, donor2	12156-128G5	25.52	0.00	1.00	0.50	2.00	3.50	0.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	34.18	1.01	1.66	0.72	2.46	2.24	0.22	1.30	0.43	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	24.31	0.00	0.00	0.00	5.40	2.70	1.35	5.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	41.13	0.00	0.00	1.48	1.97	2.96	0.99	1.72	0.00	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	38.28	0.29	0.29	0.29	2.06	1.47	0.59	0.29	0.88	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	0.00	0.00	0.00	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	32.54	0.31	0.62	0.93	1.86	1.86	0.62	1.55	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	30.29	1.04	0.21	1.45	1.04	1.04	0.41	0.62	0.41	1.66
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	0.00	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	33.28	0.00	0.50	1.25	1.00	0.25	1.00	0.00	0.00	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	29.33	0.47	1.86	1.40	2.79	2.33	0.93	0.47	0.47	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	32.51	0.41	0.81	0.81	1.83	0.20	0.20	0.00	0.00	2.44
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	25.74	0.79	0.79	0.40	3.96	2.38	0.00	0.79	0.40	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	0.00	0.00	0.00	0.00	0.00	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	25.66	0.00	0.00	0.88	0.88	0.00	0.00	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	29.64	0.38	0.76	1.14	2.28	0.76	0.38	1.52	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	1.32	0.00	1.32	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	30.14	0.42	0.42	0.85	0.21	0.42	0.64	1.49	0.21	2.12
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	17.50	0.00	0.00	0.92	2.76	1.84	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	23.84	0.30	0.00	1.19	0.60	0.60	0.30	0.60	0.00	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	0.00	0.00	1.68	1.68	1.68	1.68	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	26.09	0.50	0.50	0.75	0.75	0.25	1.00	0.75	0.00	2.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	33.75	0.00	0.24	0.71	2.14	1.19	1.19	0.24	0.24	2.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	17.69	0.00	0.55	3.32	2.21	0.55	0.00	0.00	0.00	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	28.78	0.23	0.92	0.46	1.61	0.69	0.46	0.23	0.46	3.91
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	25.45	0.63	1.26	0.84	1.47	1.89	1.05	0.21	0.21	2.52
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	23.64	0.41	0.41	1.83	1.43	0.61	1.02	0.20	0.00	3.06
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	31.97	0.21	0.64	1.07	1.07	0.00	0.43	1.07	0.00	3.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	22.90	0.00	0.67	1.11	2.00	1.33	1.33	0.44	0.22	3.78
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	21.46	0.00	0.22	0.88	0.66	0.22	1.75	0.44	0.00	1.75
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.24	0.00	0.00	0.51	3.55	3.04	2.03	0.51	0.00	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	0.00	0.00	3.31	0.00	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	25.55	0.00	0.54	0.27	0.82	1.63	1.36	0.00	0.27	2.45
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	24.41	0.29	0.88	0.88	1.47	0.88	1.47	0.59	0.00	3.23
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	11.99	0.00	1.09	3.27	2.18	1.09	3.27	1.09	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	23.55	0.00	0.00	0.48	0.96	0.96	0.48	0.96	0.48	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	30.02	0.80	0.80	0.80	2.80	1.20	2.40	2.40	0.00	4.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	26.05	0.00	0.00	4.11	0.00	0.00	8.23	5.48	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	30.54	1.00	0.00	1.50	1.50	1.50	0.50	1.50	1.00	4.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	80.84
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	0.00	0.00	2.04	2.04	2.04	4.08	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	36.35	1.75	0.44	1.75	1.31	0.44	1.31	1.31	0.88	7.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	0.00	1.10	0.00	1.10	1.10	7.73	0.00	0.00	5.52
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	21.13	0.64	0.64	1.92	1.28	2.56	7.68	0.00	0.00	2.56
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	36.94	0.74	2.48	1.74	1.98	1.49	1.98	1.98	0.74	3.22
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	17.40	0.00	0.00	0.70	2.78	1.39	4.18	1.39	0.00	4.18
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	26.52	0.00	0.00	0.00	0.00	4.42	6.63	4.42	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	46.15	1.37	0.68	1.37	1.37	1.03	4.10	2.05	2.05	12.65
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	24.51	0.00	0.88	3.50	4.38	3.50	3.50	1.31	0.88	4.38
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	32.31	0.36	2.49	5.68	1.07	0.00	7.46	1.42	0.71	4.26
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	60.88	2.81	5.33	1.96	2.24	0.56	4.21	0.00	2.81	14.03
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	34.91	0.83	2.49	2.91	6.65	0.83	3.33	0.83	0.42	5.40
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	27.97	0.58	1.75	3.50	1.17	3.50	4.08	1.75	0.00	2.33
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	35.90	1.81	2.11	1.81	2.11	1.51	2.71	1.81	2.11	10.56
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	42.16	0.83	2.09	2.92	4.59	1.67	2.92	2.09	2.50	10.85
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	0.00	7.22	21.66	0.00	0.00	21.66	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	29.55	0.92	1.85	0.92	3.69	0.92	4.62	0.00	0.00	11.08
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	36.99	1.71	2.28	2.85	5.12	2.28	8.54	0.57	2.28	11.38
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	43.39	0.41	2.90	2.21	2.35	1.93	4.97	0.28	2.35	6.36
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	43.28	0.78	4.92	3.37	2.07	1.55	5.70	3.37	3.11	7.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	36.89	0.00	2.14	5.58	4.29	2.57	4.72	0.43	0.43	8.15
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.06	0.00	1.91	2.54	1.27	0.64	4.45	0.00	0.64	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	39.50	1.07	7.74	2.40	2.14	1.33	3.47	1.87	1.60	8.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	46.70	1.80	2.10	1.80	4.49	1.80	2.10	1.50	0.90	8.98
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	38.84	0.28	2.40	2.26	1.98	1.41	2.26	0.57	2.83	3.67
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	43.95	1.91	5.73	3.50	2.55	1.27	3.50	1.27	3.82	9.87
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	48.43	1.33	4.64	2.43	2.21	2.65	4.86	1.55	3.76	12.38
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	31.85	0.38	1.14	0.38	4.55	1.52	4.93	0.00	1.52	7.96
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	61.94	2.56	6.82	3.41	4.55	0.57	5.40	3.98	6.25	11.93
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	39.82	2.21	4.18	1.72	3.44	1.23	1.97	2.95	3.93	8.60
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	38.45	1.96	1.96	2.61	1.30	0.65	2.61	3.26	0.00	2.61
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	41.75	0.29	4.12	1.47	1.76	1.18	2.94	2.94	1.47	6.17
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	42.10	0.58	5.19	2.02	2.02	1.44	2.88	2.02	4.61	9.51
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	39.98	1.65	3.71	2.47	1.65	1.65	0.82	2.89	0.82	10.72
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	39.61	1.19	2.68	1.19	2.08	1.79	1.49	1.49	0.89	4.76
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	0.00	0.00	0.00	3.77	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	0.00	0.00	0.00	3.56	1.78	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	32.86	0.99	0.33	0.99	0.66	1.31	0.00	2.63	0.00	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	24.19	0.00	0.00	1.05	0.00	3.16	0.00	2.10	0.00	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	25.11	0.20	0.79	0.99	0.99	0.79	0.20	1.78	0.20	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	26.08	0.00	0.00	1.86	0.93	0.93	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	27.79	0.38	1.50	0.75	0.38	0.00	0.38	1.13	0.00	3.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	24.77	0.00	0.27	0.27	1.07	0.80	0.53	0.53	0.27	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	41.62	1.13	1.24	0.90	1.13	0.23	0.11	1.13	0.11	1.36
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	22.84	0.74	0.00	0.00	0.00	0.00	0.00	0.74	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	28.21	0.37	0.37	1.10	2.20	1.10	0.00	2.56	0.37	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	32.67	1.56	0.00	0.00	3.11	1.56	0.00	4.67	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	45.43	0.53	0.00	0.53	1.07	0.00	0.00	0.00	0.00	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00	0.00	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	28.28	0.00	0.00	0.00	0.00	0.00	0.00	1.01	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	24.88	0.00	0.00	0.84	1.69	0.42	0.42	0.42	0.00	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	47.67	2.72	1.36	4.09	1.36	1.36	1.36	1.36	0.00	17.71
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	19.71	0.64	0.00	0.64	0.00	0.64	0.00	0.64	0.64	5.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	22.68	0.81	0.00	0.00	0.00	0.00	0.00	0.81	0.00	4.05
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	22.66	1.51	0.00	0.00	0.00	1.51	1.51	1.51	6.04	10.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	239.83	0.00	5.71	11.42	11.42	5.71	17.13	5.71	17.13	51.39
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	140.29	13.05	9.79	9.79	3.26	0.00	6.52	6.52	0.00	42.41
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	0.00	0.00	0.00	0.00	0.00	4.75	0.00	0.00	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	43.30	1.94	0.86	0.65	1.29	1.51	0.43	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	37.11	1.57	0.00	0.52	0.00	0.52	0.00	2.61	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	12.68	0.00	0.00	0.00	0.00	0.67	0.67	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	13.36	0.83	0.00	0.42	0.83	0.00	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	48.68	0.57	1.52	2.28	1.14	1.14	0.57	0.76	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	57.45	0.00	1.60	4.79	0.00	1.60	0.00	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.16	0.00	0.68	0.00	0.68	0.00	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	115.77	0.00	5.51	3.68	0.00	1.84	1.84	14.70	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	13.81	1.67	0.00	0.42	0.42	0.84	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	21.38	0.23	0.23	1.16	0.00	0.93	0.00	0.46	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.89	1.08	0.00	0.27	1.08	0.54	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	34.06	2.10	0.84	1.26	0.63	0.21	0.42	1.05	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	244.96	11.13	0.00	0.00	11.13	0.00	0.00	89.08	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	19.36	1.49	0.99	0.50	0.99	0.99	0.00	1.49	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	24.63	1.35	1.08	0.54	0.81	1.08	0.00	0.54	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.01	0.91	0.45	0.45	0.45	0.45	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.00	1.96	0.16	0.49	0.82	0.33	0.00	0.33	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	38.09	2.92	0.00	0.73	0.55	0.36	0.18	1.09	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	12.73	0.00	0.53	0.53	1.06	0.00	0.00	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	14.41	1.20	0.00	0.00	0.60	0.60	0.00	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	39.05	3.28	1.31	1.97	0.33	0.98	0.00	4.27	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.76	0.49	0.33	0.65	0.49	0.33	0.16	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	31.40	2.65	0.18	0.71	0.88	0.71	0.35	1.23	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	10.55	0.00	0.00	1.41	0.70	0.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	16.09	0.46	0.00	0.46	0.00	0.92	0.00	0.92	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	14.46	1.61	0.64	0.64	0.00	0.96	0.32	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	48.28	1.03	1.03	0.34	1.72	1.03	0.34	4.48	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	108.72	5.06	10.11	5.06	0.00	0.00	0.00	12.64	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	26.51	1.11	0.00	1.11	1.56	0.22	0.22	1.34	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	14.40	0.85	0.42	0.42	0.00	1.27	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	28.48	1.42	1.19	0.71	0.47	0.24	0.24	0.47	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.88	2.15	0.00	0.43	0.86	0.86	0.43	1.72	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	198.61	18.06	18.06	9.03	0.00	0.00	0.00	162.50	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.33	1.67	0.33	0.00	0.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	18.03	0.00	0.45	0.90	0.45	0.00	0.00	1.35	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.49	0.79	0.40	0.40	0.40	0.00	0.40	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.00	2.79	0.00	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	22.32	1.14	0.76	0.38	0.38	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.75	0.65	0.65	0.33	0.98	0.65	0.65	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.15	1.31	0.00	0.00	0.00	0.00	0.00	1.31	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	31.66	1.36	0.45	1.81	0.00	0.00	0.45	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	12.35	1.76	0.88	0.88	0.88	0.00	0.00	1.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.29	1.33	0.00	0.66	0.66	0.00	0.00	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.39	4.46	0.00	0.50	0.00	0.50	0.50	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.10	1.91	0.00	0.77	0.38	0.38	0.38	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	44.16	2.72	0.30	0.91	0.91	0.30	0.00	2.12	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	31.61	1.99	1.99	0.44	0.44	0.22	0.00	1.55	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	1.36	0.68	0.00	0.68	0.68	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	117.52	5.11	0.00	0.00	0.00	5.11	0.00	15.33	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	13.41	0.61	0.61	0.61	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.22	0.63	0.00	0.00	0.31	0.00	0.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.29	1.82	0.91	0.91	0.00	0.30	0.00	0.91	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	17.41	2.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	49.88	0.00	3.40	1.13	1.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	111.27	10.12	10.12	5.06	0.00	0.00	0.00	60.69	5.06	0.00
Myoblast, donor1	11241-116D8	47.08	0.75	2.98	1.24	0.99	1.37	0.50	0.25	0.62	0.00
Myoblast, donor2	11322-117D8	50.44	0.96	1.92	1.73	1.53	0.77	0.38	0.58	0.19	0.00
Myoblast, donor3	11398-118D3	46.41	0.84	2.19	1.18	1.35	1.18	0.00	0.84	0.50	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	113.68	6.13	2.33	1.61	0.00	0.44	0.15	3.79	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	95.33	1.23	2.15	2.77	0.00	0.00	0.00	6.46	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	71.47	0.30	0.60	0.60	0.00	0.00	0.00	15.68	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	86.69	0.55	2.21	1.29	0.18	0.55	0.00	18.59	0.00	0.55
Neural stem cells, donor1	11275-116H6	103.44	7.26	12.70	2.18	1.81	2.54	0.36	1.09	0.36	0.00
Neural stem cells, donor2	11352-117H2	102.06	19.26	13.48	1.93	1.93	0.00	0.00	1.93	0.00	0.00
Neurons, donor1	11494-119E9	66.00	5.69	13.65	5.69	0.00	1.14	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	70.67	12.33	6.16	2.20	0.88	0.88	0.00	1.32	0.00	0.22
Neurons, donor3	11655-122E8	59.20	8.22	9.87	0.00	1.64	0.82	0.00	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	80.74	0.00	0.00	1.86	0.00	0.00	0.00	6.50	0.00	0.00
Neutrophils, donor2	11314-117C9	57.98	0.00	2.90	2.90	0.00	0.00	0.00	11.60	0.00	0.00
Neutrophils, donor3	11390-118C4	67.19	0.00	1.83	1.83	0.00	0.00	0.00	1.22	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	55.57	6.41	1.54	0.24	0.24	0.24	0.00	0.83	0.24	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	30.61	4.56	1.30	0.65	0.00	0.33	0.00	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	30.28	2.81	1.20	0.80	0.20	0.00	0.00	0.40	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	21.34	0.96	0.96	0.41	0.28	0.96	0.14	3.58	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	30.69	1.45	2.03	0.14	1.59	1.45	0.29	4.20	0.14	0.14
Olfactory epithelial cells, donor3	11935-125I9	32.24	0.57	0.68	0.34	0.79	1.25	0.00	1.70	0.00	0.11
Olfactory epithelial cells, donor4	11936-126A1	31.26	0.39	0.78	0.19	0.68	0.29	0.00	2.05	0.10	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	62.59	0.60	2.41	0.60	1.20	0.00	0.00	0.60	2.41	0.00
Osteoblast - differentiated, donor1	11276-116H7	19.78	0.64	1.91	0.00	0.85	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	16.00	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	23.59	0.62	0.00	0.62	0.62	0.00	0.00	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	28.14	1.95	1.76	0.20	0.59	0.39	0.00	0.78	0.00	0.00
Osteoblast, donor2	11354-117H4	68.12	2.11	0.70	0.00	0.00	1.40	1.40	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	28.61	0.71	0.36	0.53	0.53	0.36	0.18	0.00	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	60.40	1.60	2.36	0.93	1.35	1.52	0.08	1.85	0.67	0.08
Pericytes, donor1	11491-119E6	8.12	1.56	0.56	0.33	0.22	0.22	0.00	0.45	0.00	0.00
Pericytes, donor2	11571-120E5	6.11	2.49	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	15.06	1.22	0.81	0.00	0.20	0.41	0.00	1.02	0.00	0.00
Perineurial Cells, donor1	11499-119F5	53.12	6.89	1.36	0.68	0.57	0.90	0.11	2.26	0.45	0.00
Perineurial Cells, donor2	11579-120F4	59.53	4.05	1.84	1.84	1.01	1.29	0.37	0.37	0.55	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	121.76	1.91	1.59	0.64	0.64	0.64	0.00	6.69	0.00	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	73.70	0.24	0.49	0.98	0.49	0.24	0.00	10.04	0.00	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	66.91	0.39	1.42	1.04	0.52	0.39	0.13	5.31	0.00	0.78
Placental Epithelial Cells, donor1	11278-116H9	24.63	0.24	0.96	0.72	0.24	0.24	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	25.50	0.00	2.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	19.63	2.36	1.57	0.00	0.39	0.20	0.00	0.20	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	17.09	0.63	0.32	0.32	0.32	0.32	0.32	0.00	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	33.58	0.19	0.56	0.38	0.38	0.94	0.00	1.50	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	55.08	0.78	0.91	1.17	1.31	0.26	0.13	3.92	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	38.28	0.00	1.35	0.68	1.35	1.58	0.00	0.45	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	34.74	1.70	2.02	0.85	1.07	0.43	0.11	0.75	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	37.10	0.00	1.75	0.44	3.06	0.44	0.44	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	28.94	1.43	1.00	1.00	1.72	0.57	0.43	2.01	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	20.67	0.98	0.00	0.98	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	16.89	1.23	0.92	0.92	0.92	1.23	0.00	0.31	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	68.71	1.42	1.77	0.71	1.77	0.35	0.53	1.77	0.71	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	39.51	1.70	1.53	1.36	0.68	0.34	0.34	0.51	0.68	0.00
Preadipocyte - visceral, donor1	11280-116I2	70.33	3.26	2.14	1.21	1.40	1.77	0.28	1.77	1.49	0.09
Preadipocyte - visceral, donor2	11357-117H7	44.64	1.38	0.92	1.84	3.22	0.92	0.92	0.46	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	43.68	1.67	1.46	0.63	1.67	0.84	0.42	0.52	0.73	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	73.92	3.92	6.79	2.26	0.75	0.60	0.15	3.62	5.58	0.15
Prostate Epithelial Cells, donor2	11331-117E8	31.42	0.27	2.84	0.54	2.30	0.95	0.68	1.08	1.08	0.00
Prostate Epithelial Cells, donor3	11404-118D9	20.82	0.12	0.92	0.43	0.37	0.31	0.12	1.65	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	47.38	1.48	2.73	0.91	1.59	1.03	0.23	0.57	0.57	0.00
Prostate Stromal Cells, donor2	11332-117E9	50.56	1.26	3.05	0.54	0.54	0.54	0.18	2.15	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	32.01	1.25	1.46	0.94	0.73	1.36	0.31	1.25	0.00	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.41	0.00	0.36	0.36	0.36	0.36	0.36	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	39.09	0.76	2.01	1.11	0.42	0.83	0.42	0.90	0.49	0.07
Renal Epithelial Cells, donor1	11517-119H5	9.13	0.51	0.00	0.00	0.51	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	8.54	0.71	0.00	0.71	0.00	0.00	0.00	2.85	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	58.65	1.38	2.86	0.95	1.69	0.74	0.21	1.06	0.64	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.21	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	14.55	0.54	0.94	0.81	1.48	0.40	0.27	0.13	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	31.97	1.33	0.89	1.11	1.11	0.67	0.44	0.67	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.99	0.00	0.00	0.00	0.00	0.00	0.67	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	14.53	0.00	0.44	0.22	1.10	0.00	0.00	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	9.40	0.00	0.00	0.00	0.00	0.63	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	7.77	0.55	0.00	0.28	0.28	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	20.67	0.27	0.27	1.34	1.34	0.54	0.27	0.54	1.07	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.81	0.00	0.00	0.00	0.42	0.00	0.42	0.42	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	16.39	0.58	0.19	0.39	0.58	0.58	0.00	0.39	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	64.56	1.81	1.81	0.78	0.78	0.78	0.00	0.78	2.07	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	18.48	1.99	0.57	0.00	1.99	0.00	0.00	0.85	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	15.44	1.03	1.03	0.00	0.00	0.00	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	57.21	3.01	2.26	1.51	2.26	0.25	0.00	0.50	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	68.42	0.67	1.20	0.80	1.60	1.07	0.13	8.95	0.00	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.06	0.89	0.00	0.89	0.00	0.00	0.00	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	45.13	1.65	1.10	1.10	0.55	0.00	0.00	6.05	7.71	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	69.61	2.90	2.90	0.00	0.58	0.58	0.00	0.58	5.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	57.99	3.12	1.43	1.56	0.26	0.26	0.13	1.95	4.94	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	43.20	2.09	0.79	1.29	0.30	0.00	0.10	2.09	2.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	69.38	3.46	2.34	1.23	0.56	0.45	0.45	3.68	6.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	78.64	3.60	2.98	1.74	0.62	0.99	0.74	1.36	6.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	49.76	2.21	2.21	1.98	0.12	0.35	0.00	1.28	3.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	61.25	1.62	1.39	2.77	0.46	0.23	0.00	3.24	6.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	51.07	1.10	1.23	1.64	1.10	0.14	0.41	1.23	3.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	54.16	2.12	1.66	1.97	0.30	0.91	0.15	0.91	4.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	57.88	1.61	2.69	1.43	0.54	0.36	0.18	1.43	4.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	47.34	1.86	0.43	1.00	0.43	0.72	0.14	2.44	3.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	50.33	1.61	1.29	0.64	0.32	0.32	0.11	1.50	4.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	53.33	2.21	1.77	0.89	0.66	0.22	0.22	5.09	3.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	45.31	2.29	0.76	0.96	0.96	0.19	0.00	0.76	3.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	52.54	1.68	1.49	1.58	0.84	0.28	0.09	0.84	2.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	70.84	4.70	2.07	1.32	1.69	1.13	0.19	4.32	9.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	48.70	1.86	0.53	2.12	0.13	0.53	0.13	1.73	1.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	54.12	1.75	1.36	1.27	1.17	0.78	0.29	0.78	2.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	61.87	2.86	2.10	2.10	0.38	0.19	0.19	1.72	3.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	48.27	1.07	0.85	0.85	0.53	0.32	0.32	1.07	2.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	52.14	2.52	1.68	0.84	0.56	0.28	0.00	1.40	4.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	57.59	2.22	2.22	1.54	0.34	0.17	0.17	2.56	4.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	48.86	1.28	0.91	1.64	0.36	0.73	0.00	0.91	1.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	52.61	1.96	1.23	0.98	0.25	0.49	0.25	2.58	3.07	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	61.38	2.01	2.15	0.81	0.27	0.40	0.27	2.42	4.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	46.00	2.12	0.94	1.18	0.71	0.71	0.24	1.89	4.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	50.40	0.79	3.37	0.40	0.40	0.60	0.20	2.18	3.97	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	48.41	1.64	1.64	1.40	0.94	1.17	0.00	3.74	4.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	48.11	1.24	1.24	1.24	0.00	0.41	0.41	0.62	3.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	55.08	1.77	1.11	1.11	0.00	0.88	0.22	4.20	4.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	52.85	2.09	2.09	1.88	0.63	0.84	0.21	3.55	1.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	51.41	1.21	1.21	1.21	0.40	0.13	0.13	1.62	2.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	53.13	1.02	1.19	1.70	0.68	0.51	0.00	1.19	1.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	55.91	1.93	1.35	3.47	0.77	0.58	0.39	2.51	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	49.86	1.55	2.24	2.06	0.17	0.34	0.00	1.89	2.92	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	43.21	1.78	1.10	1.65	0.69	0.55	0.27	0.82	1.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	54.01	0.99	2.63	1.97	1.15	0.99	0.00	3.45	3.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	43.29	2.05	1.19	1.70	0.34	0.51	0.34	1.36	4.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	55.04	1.78	2.66	1.33	1.04	0.59	0.00	1.33	5.03	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	43.45	1.87	0.80	2.40	1.07	0.80	0.00	1.33	5.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	42.45	3.59	1.52	1.38	0.14	0.00	0.00	1.24	3.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	52.86	1.90	0.71	2.62	0.24	0.24	0.00	1.43	4.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	50.59	4.03	1.21	1.41	1.01	0.60	0.00	0.81	2.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	38.99	2.64	0.57	1.32	0.19	0.47	0.00	0.94	3.77	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	52.40	4.89	0.70	0.70	0.70	0.00	0.00	3.84	3.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	34.75	4.53	1.21	0.91	0.30	0.00	0.30	2.72	2.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	42.84	2.08	0.61	2.20	0.24	0.49	0.00	2.08	6.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	76.85	3.20	2.77	1.46	1.02	0.58	0.15	8.88	8.01	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	45.02	1.22	1.83	0.61	0.00	0.00	0.00	3.04	3.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	36.47	0.90	0.00	1.51	0.30	0.90	0.30	0.60	4.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	39.36	2.04	0.68	0.90	1.13	0.68	0.00	3.62	2.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	36.54	3.59	0.90	1.20	0.60	0.00	0.00	4.19	5.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	45.34	2.72	0.94	1.06	0.24	0.35	0.12	1.53	4.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	39.27	1.71	0.64	0.85	0.85	0.00	0.21	2.13	2.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	40.87	1.20	2.40	1.80	0.60	0.60	0.60	4.21	5.41	0.00
Schwann Cells, donor1	11498-119F4	14.29	2.82	0.38	0.75	0.00	0.38	0.38	0.56	0.38	0.00
Schwann Cells, donor2	11578-120F3	37.43	0.00	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	28.92	3.72	1.53	1.53	1.10	0.66	0.22	0.22	0.22	0.00
Sebocyte, donor1	11220-116B5	51.49	0.00	6.03	0.00	2.74	1.64	0.00	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	43.66	0.46	2.76	0.00	0.92	0.92	0.00	0.00	1.38	0.00
Sebocyte, donor3	11378-118B1	16.70	0.41	0.82	0.41	0.21	0.00	0.41	0.21	0.82	0.00
Sertoli Cells, donor1	11255-116F4	61.29	0.00	1.66	0.00	0.00	0.00	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	50.84	2.82	2.82	0.00	0.00	0.00	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	49.71	3.34	2.90	0.53	0.53	0.35	0.00	1.67	0.26	0.00
Skeletal Muscle Cells, donor2	11358-117H8	13.73	2.17	0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	25.92	3.34	0.00	0.00	0.00	0.84	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	63.78	2.51	0.94	1.26	0.47	0.94	0.31	1.26	0.94	0.00
Skeletal Muscle Cells, donor5	11455-119A6	52.77	3.27	1.93	0.59	0.30	1.04	0.15	2.08	1.04	0.00
Skeletal Muscle Cells, donor6	11459-119B1	65.10	1.23	2.31	1.08	0.62	0.77	0.31	2.31	1.39	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	74.97	5.04	5.42	1.01	0.50	1.01	0.13	2.27	2.39	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	55.22	2.71	2.14	1.14	0.57	0.57	0.14	2.28	0.71	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	70.04	3.08	1.88	1.59	0.89	0.89	0.30	1.49	1.39	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	70.27	4.13	3.71	1.52	0.59	0.34	0.08	1.52	0.59	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	26.06	2.17	1.45	0.72	0.00	0.72	0.72	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	19.95	0.41	0.55	0.28	0.28	0.69	0.14	0.00	0.41	0.00
Skin - palm, donor1	10286-104F7	83.27	0.00	2.69	0.00	5.37	2.69	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	15.28	0.29	0.58	0.29	0.86	0.29	0.43	0.00	0.43	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	87.51	0.00	9.81	5.73	1.64	0.00	1.64	17.99	5.73	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	16.23	0.78	0.91	0.13	0.78	0.39	0.00	0.13	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	48.93	0.70	2.36	1.53	1.81	0.83	0.42	1.11	1.25	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	31.79	0.28	2.25	0.14	1.41	0.84	0.42	0.98	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	96.42	1.06	5.50	2.75	3.17	1.27	0.00	8.03	3.59	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	24.58	0.07	0.60	0.82	1.20	0.97	0.30	0.82	0.07	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	27.46	0.31	0.93	1.23	0.62	0.31	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	45.36	0.22	1.56	0.89	0.00	0.22	0.00	2.22	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	26.45	1.18	0.59	0.59	1.18	1.18	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	44.42	0.22	1.77	1.10	0.44	0.44	0.00	0.44	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	22.45	0.00	1.58	0.00	1.18	0.79	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.00	0.00	1.55	0.77	0.00	1.55	0.77	0.00	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	32.02	3.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	28.48	0.80	0.67	0.40	0.27	0.80	0.00	0.27	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	35.24	1.33	1.77	0.66	1.33	1.33	0.22	0.89	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	37.13	0.38	2.43	0.38	1.15	1.15	0.26	0.13	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	34.51	9.44	3.58	0.33	1.63	1.30	0.65	1.30	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	41.64	3.54	1.48	2.07	0.89	0.59	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	27.62	0.57	0.43	0.28	1.00	2.28	0.57	0.43	0.43	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.46	0.00	0.16	0.33	0.65	0.33	0.16	0.16	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	32.27	0.91	2.44	0.30	1.22	0.30	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	21.72	0.51	1.52	0.00	0.51	0.25	0.00	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	146.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	15.26	0.00	0.48	0.00	0.48	0.95	0.00	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	40.41	1.77	2.65	1.18	1.03	0.29	0.00	1.62	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	30.99	1.72	1.08	0.65	0.65	0.00	0.43	1.29	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	42.19	1.57	2.20	0.94	0.63	0.73	0.42	0.52	0.52	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	27.69	0.62	0.93	0.46	1.08	1.55	0.15	0.00	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	0.00	1.08	0.00	0.00	0.00	1.08	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	26.30	0.60	0.30	0.00	0.30	0.60	0.60	0.00	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	12.63	0.34	0.68	0.00	1.37	0.34	0.34	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	66.51	4.16	2.04	0.71	0.63	0.24	0.00	2.36	0.24	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	43.28	0.50	4.53	0.70	1.61	1.61	0.10	0.10	0.40	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	46.19	1.14	3.41	1.37	1.14	1.14	0.91	1.59	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	20.53	0.00	0.00	0.60	1.21	0.00	0.00	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	91.13	2.65	4.77	2.65	1.85	0.79	0.26	2.12	0.79	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	52.86	2.13	2.66	0.40	0.93	1.20	0.00	1.20	0.40	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	39.32	2.38	2.75	0.75	0.75	0.63	0.13	2.25	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	24.35	2.28	2.03	0.76	0.25	1.01	0.00	0.76	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	35.73	1.21	2.71	0.45	1.66	1.51	0.15	0.15	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.00	0.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	129.22	1.29	0.00	0.00	1.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	25.58	0.47	1.40	0.47	0.47	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	27.77	0.50	1.01	0.00	0.50	1.51	0.00	1.51	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.98	0.31	1.88	0.31	1.88	0.31	0.00	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.60	0.00	1.47	0.29	0.59	0.00	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	80.14	2.33	3.75	1.92	0.92	1.08	0.33	0.42	0.67	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	25.69	0.93	0.00	0.00	0.47	0.00	0.00	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	20.72	0.29	0.86	0.72	1.58	0.72	0.00	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	28.30	0.76	1.78	0.76	0.51	1.02	0.00	0.25	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	17.30	0.38	0.94	0.38	0.38	0.19	0.38	0.00	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	64.00	2.38	3.21	1.82	0.84	1.12	0.28	0.84	1.54	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	44.74	0.92	2.68	0.50	0.67	1.01	0.17	0.08	0.17	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	0.00	0.00	0.00	0.48	0.95	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	25.44	0.98	0.98	0.98	0.73	0.98	0.24	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	42.20	0.66	2.21	0.44	0.88	0.66	0.00	0.88	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	27.21	0.00	1.17	0.88	0.59	0.00	0.00	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	24.30	1.55	0.58	0.58	0.39	0.39	0.00	0.97	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	24.86	0.00	0.53	0.26	0.26	0.79	0.00	1.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	29.38	1.86	4.84	0.37	0.37	0.37	0.00	3.35	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	31.98	0.72	1.80	0.72	0.36	0.36	0.72	1.80	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	27.54	0.85	1.14	0.57	1.70	1.14	0.28	0.85	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	36.63	0.39	0.79	0.39	1.18	0.39	0.00	1.58	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	27.68	0.51	2.79	0.76	0.51	0.00	0.00	1.27	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	26.75	1.20	0.80	0.40	0.40	0.00	0.00	1.60	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	20.06	1.25	0.42	0.42	0.84	0.84	0.00	0.84	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	31.17	1.83	0.00	0.92	0.92	0.46	0.00	0.92	0.00	0.00
Synoviocyte, donor1	11291-117A4	37.37	2.02	1.68	0.50	0.50	0.67	0.00	1.01	0.17	0.00
Synoviocyte, donor2	11368-117I9	36.04	1.51	1.34	0.67	1.01	0.17	0.00	1.01	0.00	0.00
Synoviocyte, donor3	11440-118H9	29.49	2.01	0.67	0.00	0.22	0.67	0.00	2.46	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	18.94	1.07	1.07	0.00	0.00	0.00	0.36	1.07	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	16.44	0.93	0.46	0.23	0.00	0.00	0.00	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	39.86	0.50	2.44	1.36	1.15	1.15	0.14	0.57	0.50	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	16.24	0.00	1.16	0.00	2.71	0.39	0.00	0.00	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	22.33	0.57	0.00	1.72	1.15	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	74.31	1.35	1.97	0.74	1.60	0.74	0.00	6.52	0.00	0.74
Urethra, donor2	10319-105A4	61.15	0.00	1.80	1.80	1.80	0.00	1.80	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	7.70	0.00	0.53	0.27	0.53	0.00	0.27	0.53	0.27	0.00
Urothelial Cells, donor2	11600-120H7	12.02	0.00	0.00	0.40	0.80	0.00	0.40	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	7.11	0.00	0.00	0.00	0.23	0.23	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	46.36	0.67	1.78	1.34	1.56	0.67	0.22	1.34	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	77.41	0.00	0.00	1.78	0.89	0.00	0.00	2.67	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	85.78	0.00	2.86	1.43	0.00	0.00	0.00	5.72	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	54.76	0.68	0.68	0.68	0.00	0.00	0.00	4.79	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	65.08	0.69	0.69	0.34	0.00	0.00	0.00	5.51	0.00	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	72.63	1.16	0.58	1.16	0.00	0.00	0.00	6.97	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	69.76	0.00	2.08	1.04	0.00	0.00	0.00	7.29	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	89.03	0.00	3.67	3.67	0.00	0.00	0.00	9.18	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	47.47	1.83	0.91	0.00	1.83	0.00	0.00	5.48	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	46.63	8.27	4.32	0.62	2.47	1.85	0.37	2.59	18.87	0.00
Wilms' tumor cell line:HFWT	10597-108E3	40.48	0.88	1.76	0.88	0.88	1.76	0.00	2.64	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	45.25	0.00	0.84	0.28	1.12	1.68	0.00	3.35	1.12	0.00
achilles tendon, donor2	10292-104G4	103.33	0.00	0.00	0.00	0.00	0.00	2.07	14.47	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	75.21	7.39	7.39	1.02	0.25	0.00	0.00	7.14	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	101.92	5.80	3.48	1.63	0.46	0.46	0.23	4.88	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	118.35	12.11	3.44	3.56	0.00	0.12	0.12	8.07	0.12	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	106.67	19.59	6.80	3.27	0.54	1.90	0.00	3.54	1.63	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	76.74	4.50	2.53	2.25	0.28	0.00	0.00	5.62	8.71	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	82.90	5.29	6.34	1.06	0.42	0.42	0.00	0.63	2.75	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	23.95	2.45	2.72	0.00	0.00	0.27	0.00	5.72	8.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	83.28	2.64	3.08	1.76	0.44	0.88	0.00	3.53	22.03	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	54.72	4.49	1.23	1.63	0.82	0.00	0.00	6.53	58.80	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	93.97	6.60	1.16	3.88	1.16	0.00	0.39	6.21	2.72	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	115.37	1.10	2.02	4.23	0.37	0.55	0.00	2.94	9.75	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	0.00	7.80	3.90	0.00	0.00	0.00	7.80	54.61	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	77.85	23.47	3.49	1.16	0.23	0.46	0.46	0.93	3.02	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	121.42	2.59	4.14	2.85	0.26	0.52	0.00	5.18	1.04	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	99.36	3.51	1.75	2.05	0.29	0.00	0.29	4.68	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	69.71	1.39	1.86	2.79	0.93	0.46	0.00	2.32	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	60.04	0.00	2.06	2.47	0.00	0.41	0.00	3.70	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	43.59	0.00	0.92	4.30	1.84	0.92	0.00	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	122.04	1.71	3.41	1.28	1.71	2.13	0.00	3.41	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	132.84	2.43	4.25	4.85	2.12	0.61	0.00	3.34	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	137.44	2.89	4.57	3.85	0.24	0.72	0.00	1.44	0.72	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	81.97	0.22	1.78	0.89	0.00	0.00	0.00	2.67	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	76.72	3.00	1.67	4.34	0.33	0.00	0.67	3.67	31.35	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	74.33	3.72	3.72	0.00	0.00	1.86	0.00	5.57	5.57	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	33.52	1.13	0.38	0.75	0.00	0.00	0.00	1.13	18.08	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	47.97	4.80	1.74	2.18	0.00	0.00	0.87	3.49	36.64	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	44.99	5.62	5.62	1.87	0.00	0.00	0.00	18.74	18.74	0.00
adenocarcinoma cell line:IM95m	10796-110I4	54.16	0.47	1.18	0.24	0.47	0.47	0.00	1.65	1.18	0.00
adipose tissue, adult, pool1	10010-101C1	51.65	0.47	1.86	1.24	0.00	0.62	0.00	2.17	0.00	0.31
adipose, donor1	10184-103D4	92.07	12.31	5.28	2.35	0.59	0.00	0.00	17.59	11.73	0.00
adipose, donor2	10185-103D5	24.74	5.68	2.84	1.22	0.41	0.00	0.00	9.33	2.03	0.41
adipose, donor3	10186-103D6	63.44	14.43	5.72	1.36	0.27	0.27	0.00	10.35	1.63	0.00
adipose, donor4	10187-103D7	203.69	13.00	2.60	0.87	0.87	0.00	0.87	5.20	13.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	45.77	5.05	1.42	1.58	2.05	0.79	0.00	1.89	6.79	0.00
adrenal gland, adult, pool1	10081-102A9	40.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	64.17	0.27	0.40	1.20	0.13	0.00	0.13	3.07	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	80.39	3.22	0.00	2.14	1.43	2.14	0.36	3.93	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	27.13	0.00	1.39	0.70	0.46	0.46	0.00	2.09	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	59.84	0.00	0.00	0.34	1.69	0.34	0.00	0.68	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	33.00	0.00	2.36	0.88	0.88	0.88	0.00	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	77.08	2.37	13.04	1.19	8.30	2.37	1.19	7.11	0.00	0.00
amygdala, adult, donor10252	10151-102I7	94.08	2.23	7.50	2.43	6.49	2.03	0.61	5.27	0.61	0.00
amygdala, newborn, donor10223	10360-105E9	39.70	6.78	4.52	2.26	0.97	3.55	1.29	6.78	2.90	2.90
anaplastic carcinoma cell line:8305C	10428-106D5	95.24	4.97	0.38	3.06	1.02	0.51	0.00	2.16	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	63.10	4.63	2.21	1.54	0.22	0.22	0.44	4.19	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	45.76	10.69	2.34	1.34	0.33	0.33	0.00	13.70	0.33	0.00
aorta, adult, pool1	10052-101G7	29.42	0.39	1.18	0.59	0.39	0.00	0.00	3.73	0.00	0.00
appendix, adult	10189-103D9	86.55	2.33	1.16	3.10	0.00	0.39	0.00	3.88	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	84.61	5.85	4.47	1.03	0.69	0.69	0.00	4.82	4.13	0.00
artery, adult	10190-103E1	67.93	2.72	0.00	1.36	0.00	0.00	0.00	6.79	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	78.81	6.95	4.78	0.72	0.43	0.29	0.00	3.77	1.74	0.14
b cell line:RPMI1788	10427-106D4	73.31	1.64	1.78	1.34	0.00	0.30	0.15	5.80	0.30	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	44.39	0.28	0.28	1.66	0.55	0.55	0.28	1.11	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	100.42	1.29	4.56	1.09	2.18	1.69	0.30	2.18	1.39	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	38.83	0.33	0.00	1.34	0.67	0.17	0.00	5.36	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	87.24	0.00	1.12	3.36	0.00	0.00	0.00	2.80	1.12	0.56
bladder, adult, pool1	10011-101C2	39.65	0.54	0.87	0.54	0.00	0.33	0.00	3.37	0.00	0.33
blood, adult, pool1	10053-101G8	42.08	2.21	2.21	0.00	0.00	0.00	0.00	4.43	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	31.68	0.86	4.28	0.00	0.00	1.71	0.86	1.71	0.00	0.00
bone marrow, adult	10192-103E3	66.81	4.72	1.35	0.67	0.00	0.00	0.00	2.70	0.00	0.00
brain, adult, donor1	10084-102B3	32.80	1.03	3.08	1.03	3.08	1.03	1.03	1.03	1.03	0.00
brain, adult, pool1	10012-101C3	79.40	2.45	11.14	1.00	2.23	1.89	0.11	1.67	1.22	0.11
brain, fetal, pool1	10085-102B4	37.40	16.03	2.67	2.67	5.34	0.00	0.00	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	52.86	0.33	0.66	1.65	0.66	1.98	0.00	1.98	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	27.59	0.12	1.37	0.62	0.62	0.25	0.00	1.62	0.75	0.00
breast, adult, donor1	10080-102A8	25.89	0.00	0.63	1.26	0.00	0.63	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	85.62	1.14	1.40	2.41	2.54	0.64	0.00	4.07	0.25	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	30.61	0.62	0.62	1.86	0.62	0.62	0.00	3.71	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	72.29	5.53	2.76	1.38	5.06	1.38	0.46	9.21	6.22	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	56.16	0.48	0.73	1.21	2.42	1.21	0.24	2.91	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	78.05	0.94	1.88	0.94	0.47	0.00	0.94	6.58	2.82	0.00
carcinoid cell line:NCI-H727	10735-110B6	43.42	0.55	2.41	0.77	0.44	0.55	0.11	0.66	0.11	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	56.41	4.44	0.00	0.63	1.27	0.95	0.00	5.07	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	88.10	14.64	4.79	1.06	1.86	0.27	0.00	3.99	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	67.93	2.30	6.91	0.00	14.97	2.30	0.00	8.06	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	96.55	4.35	13.22	0.50	12.55	3.51	0.33	3.35	0.67	0.17
caudate nucleus, adult, donor10258	10379-105H1	45.85	3.06	6.11	0.76	17.58	5.35	1.53	6.88	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	58.23	8.06	5.86	2.20	5.13	4.03	0.37	8.42	6.23	3.66
cerebellum - adult, donor10196	10173-103C2	154.40	17.48	8.74	2.91	0.00	0.00	0.00	23.31	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	149.24	12.81	5.34	2.99	0.85	0.64	0.43	8.33	0.00	0.00
cerebellum, adult, pool1	10083-102B2	58.64	6.90	2.41	0.34	0.34	0.69	0.00	6.90	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	84.69	29.06	4.98	1.66	0.00	0.00	0.00	12.45	4.15	0.00
cerebral meninges, adult	10188-103D8	68.58	1.51	5.29	1.01	4.54	1.51	0.00	0.50	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	73.09	1.46	1.46	1.46	2.92	0.00	0.00	4.39	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	117.18	1.29	3.02	1.87	3.16	2.01	0.00	3.16	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	95.12	1.16	6.96	1.49	0.83	0.99	0.17	1.16	0.33	0.00
cervix, adult, pool1	10013-101C4	52.71	1.78	2.31	1.68	1.05	0.21	0.10	5.77	0.10	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	80.26	0.56	1.81	2.37	1.53	1.39	0.28	0.84	0.14	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	1.31	0.00	1.31	0.00	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	110.85	0.25	1.49	1.74	0.75	0.37	0.12	3.98	14.17	0.12
choriocarcinoma cell line:SCH	10785-110H2	56.31	1.85	2.22	0.49	0.49	0.37	0.00	4.44	1.36	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	80.40	0.24	2.13	3.08	0.95	0.24	0.24	2.85	2.85	0.00
chorionic membrane cells, donor1	12238-129G6	23.65	0.00	1.99	0.85	0.57	0.28	0.00	1.14	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	55.38	1.29	1.19	1.19	1.09	1.39	0.10	0.70	0.30	0.00
chorionic membrane cells, donor3	12240-129G8	34.62	0.00	0.00	1.65	1.10	0.00	0.00	1.65	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	69.68	6.06	0.00	2.02	0.00	0.00	0.00	4.04	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	64.93	0.38	1.54	1.54	0.19	0.19	0.19	3.27	14.60	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	64.20	1.90	3.17	0.84	0.42	0.21	0.00	3.38	4.01	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	87.31	0.51	1.03	1.03	0.26	0.00	0.00	2.57	18.49	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	76.68	0.24	3.14	3.87	0.24	0.24	0.24	3.63	21.77	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	89.38	0.61	0.81	1.43	0.61	0.61	0.00	3.26	27.08	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	105.12	2.94	4.42	2.94	1.18	0.88	0.29	6.48	31.21	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	107.38	5.99	14.86	2.09	0.26	0.26	0.00	4.17	21.37	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	66.75	1.60	2.29	1.37	2.06	1.37	0.23	5.03	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	37.65	0.52	0.52	0.87	1.04	0.52	0.00	1.39	1.04	0.00
colon carcinoma cell line:CACO-2	10513-107D9	87.31	5.31	6.41	1.83	0.37	1.28	0.18	2.93	15.19	0.18
colon carcinoma cell line:COLO-320	10420-106C6	160.77	3.04	2.66	1.52	0.76	0.38	0.00	6.84	26.99	0.00
colon, adult, donor1	10082-102B1	38.08	0.00	0.00	2.38	0.00	0.00	1.19	4.76	0.00	0.00
colon, adult, pool1	10014-101C5	52.29	0.71	1.41	1.29	0.71	0.47	0.00	2.94	0.00	0.24
colon, fetal, donor1	10070-101I7	34.61	0.62	0.00	1.85	0.00	1.85	0.00	3.09	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	146.67	22.92	4.58	0.00	0.00	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	140.23	12.32	3.40	3.82	0.42	0.00	0.85	8.07	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	107.16	11.77	1.51	2.57	0.60	0.45	0.45	4.53	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	106.60	10.01	2.82	2.68	0.28	0.56	0.14	3.24	0.00	0.42
corpus callosum, adult, pool1	10042-101F6	79.27	2.21	6.19	2.10	1.66	1.66	0.11	7.30	0.33	0.00
cruciate ligament, donor2	10295-104G7	80.24	0.00	0.00	0.00	0.00	0.81	0.00	8.10	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	44.14	0.80	4.01	0.00	0.00	0.00	0.00	5.62	0.00	0.00
diencephalon, adult	10193-103E4	45.84	0.72	5.76	1.92	2.88	1.92	0.00	1.68	0.48	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	86.10	8.95	3.67	1.15	0.23	0.00	0.23	4.13	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	107.19	1.03	6.15	2.56	1.54	0.77	0.00	3.33	0.77	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	60.42	6.26	6.50	2.41	3.13	2.89	0.24	3.61	17.33	0.00
ductus deferens, adult	10196-103E7	52.33	0.50	0.50	1.50	1.50	3.49	0.00	3.99	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	0.00	4.32	0.00	1.44	0.00	0.00	14.40	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	58.85	2.21	2.94	1.47	0.74	0.74	0.00	13.98	0.00	0.00
dura mater, adult, donor1	10041-101F5	86.72	3.80	4.38	0.74	0.58	0.83	0.17	3.22	0.17	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	110.37	9.99	16.88	4.22	0.44	0.22	0.00	2.89	5.77	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	127.96	7.59	4.16	4.01	0.57	1.00	0.43	3.87	3.44	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	45.01	0.00	0.00	1.85	0.62	0.62	0.00	2.47	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	54.79	1.82	1.21	2.12	2.42	1.21	0.00	1.51	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	62.06	2.78	0.31	0.93	3.09	0.62	0.31	2.47	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	64.36	0.00	0.00	5.25	2.63	3.94	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	34.86	7.71	8.04	0.34	0.34	1.68	0.00	6.70	17.43	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	26.64	1.09	1.09	0.54	1.09	0.72	0.00	1.09	0.91	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	46.31	4.50	3.38	0.80	3.06	1.93	0.32	0.80	3.54	0.00
epidermoid carcinoma cell line:A431	10426-106D3	73.03	0.56	2.56	1.56	1.11	1.22	0.11	1.45	1.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	87.99	1.54	2.53	1.43	0.88	0.77	0.11	2.09	0.22	0.00
epididymis, adult	10197-103E8	52.12	1.67	2.51	1.47	0.21	1.26	0.00	7.74	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	43.11	2.13	0.18	0.71	1.24	0.18	0.35	1.60	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	38.14	3.15	0.79	2.36	1.97	0.79	0.00	1.18	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	104.05	1.83	0.66	1.44	1.18	1.18	0.13	4.06	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	123.12	2.66	1.67	2.46	1.18	1.28	0.00	1.67	0.00	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	109.45	1.79	1.01	1.12	1.57	0.56	0.22	2.13	0.11	0.00
esophagus, adult, pool1	10015-101C6	43.75	0.21	0.85	0.85	1.06	0.53	0.00	2.23	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	48.22	16.66	4.88	1.50	1.75	3.88	0.75	5.39	5.39	0.00
eye - muscle inferior rectus, donor1	10272-104E2	82.10	0.00	12.07	0.00	0.00	0.00	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	48.40	0.00	0.00	0.00	0.00	2.10	0.00	6.31	0.00	2.10
eye - muscle medial, donor2	10299-104H2	49.11	0.00	1.49	5.95	1.49	0.00	0.00	8.93	0.00	0.00
eye - muscle superior, donor2	10297-104G9	61.91	2.29	0.00	1.15	1.15	1.15	0.00	3.44	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	69.95	2.91	1.46	2.91	0.00	0.00	0.00	5.83	0.00	1.46
eye, fetal, donor1	10054-101G9	46.02	3.56	3.05	0.51	0.25	0.25	0.00	0.76	0.76	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	47.19	2.44	3.21	1.41	0.90	0.77	0.00	1.41	7.31	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	99.00	8.07	2.37	4.04	3.80	1.42	0.71	2.85	11.63	0.00
frontal lobe, adult, pool1	10040-101F4	116.62	5.91	14.54	1.50	4.32	2.25	0.84	4.03	1.88	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	72.66	0.90	3.60	0.60	1.50	0.90	0.30	6.61	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	56.05	0.55	0.73	1.28	0.82	0.37	0.00	2.74	0.91	0.00
gall bladder, adult	10198-103E9	36.70	0.72	0.72	0.48	0.97	0.24	0.00	2.17	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	82.68	0.00	0.54	2.15	0.00	0.00	0.00	3.76	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	72.08	1.49	1.49	1.12	0.00	0.00	0.00	6.72	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	95.89	1.27	2.53	2.53	5.07	1.90	0.42	3.38	0.84	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	86.46	1.74	3.87	0.19	1.93	0.00	0.00	1.16	0.97	0.00
gastric cancer cell line:AZ521	10549-107H9	87.55	8.85	2.30	1.97	1.97	1.48	0.00	3.44	10.33	0.00
gastric cancer cell line:GSS	10560-108A2	56.74	7.32	0.92	1.83	0.00	1.83	0.00	12.81	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	55.06	9.82	9.14	0.00	0.23	0.00	0.23	6.63	5.71	0.00
giant cell carcinoma cell line:LU65	10487-107B1	62.42	0.34	1.49	1.26	0.69	0.00	0.00	1.61	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	131.84	2.24	1.54	1.82	1.68	1.40	0.28	3.22	5.74	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	78.82	0.75	2.74	2.24	1.50	1.50	0.50	4.24	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	69.24	7.49	2.74	1.79	3.80	2.11	0.32	1.79	0.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	70.22	6.88	2.53	1.69	3.79	1.97	0.28	1.54	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	67.33	5.19	2.10	1.66	1.32	1.88	0.00	2.32	0.44	0.00
glioma cell line:GI-1	10413-106B8	51.55	2.05	1.46	0.29	0.59	0.59	0.00	4.39	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	58.31	1.46	3.64	0.73	4.37	0.00	0.00	5.83	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	118.14	1.95	7.32	0.49	2.44	2.20	0.00	8.06	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	83.52	1.37	9.58	1.37	4.11	0.00	0.00	19.17	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	35.71	4.80	3.20	2.13	3.20	2.66	0.53	3.73	1.60	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	129.70	2.45	7.34	0.00	4.89	2.45	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	10.93	0.00	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	0.00	5.23	0.00	0.00	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	32.32	1.60	1.28	0.00	0.00	0.00	0.00	0.96	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	56.93	16.99	5.51	2.30	0.00	0.46	0.00	4.13	9.18	0.00
hIPS +CCl2, biol_rep2	14384-156C1	54.87	12.35	4.12	1.83	0.46	0.00	0.46	3.20	9.60	0.00
hIPS +CCl2, biol_rep3	14385-156C2	49.60	14.17	7.09	0.00	0.64	0.00	0.00	3.22	14.81	0.00
hIPS, biol_rep1	14380-156B6	41.68	18.68	1.44	5.75	0.00	0.00	0.00	4.31	20.12	0.00
hIPS, biol_rep2	14381-156B7	50.75	13.03	5.49	0.69	0.00	0.00	0.00	4.80	7.54	0.00
hIPS, biol_rep3	14382-156B8	59.59	0.00	6.62	4.41	4.41	0.00	0.00	1.10	3.31	0.00
hairy cell leukemia cell line:Mo	10712-109I1	74.42	9.19	0.29	2.59	0.00	0.00	0.29	4.60	1.44	0.29
heart - mitral valve, adult	10205-103F7	58.30	0.90	0.90	1.49	0.30	1.20	0.00	3.89	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	70.34	0.78	4.71	1.05	0.52	0.52	0.26	4.97	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	87.43	1.67	0.83	1.67	0.00	2.50	0.00	8.33	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	31.83	0.41	1.63	0.41	0.82	0.82	0.00	2.86	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	33.21	0.00	1.28	1.28	0.00	0.00	0.00	3.83	0.00	0.00
heart, adult, pool1	10016-101C7	46.69	0.00	0.92	1.38	1.15	1.38	0.00	0.92	0.00	0.00
heart, fetal, pool1	10046-101G1	78.96	3.08	3.80	1.23	0.51	0.51	0.10	4.11	0.41	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	24.37	0.62	0.93	1.23	1.54	0.62	0.00	1.54	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	49.95	1.19	0.00	3.57	1.19	0.00	0.00	3.57	4.76	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	103.20	8.95	3.76	2.32	1.22	1.10	0.33	3.20	29.94	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	125.99	8.25	4.25	2.43	1.82	0.85	0.49	2.18	31.92	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	128.94	9.20	4.35	2.32	2.22	0.91	0.61	3.74	33.35	0.00
hepatoma cell line:Li-7	10484-107A7	110.21	6.90	5.78	2.56	2.22	1.67	0.44	2.78	5.67	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	88.64	2.41	6.73	0.90	0.10	0.40	0.30	1.61	2.51	0.10
hippocampus - adult, donor10196	10169-103B7	80.44	4.73	7.57	1.89	2.84	1.89	0.95	6.62	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	96.74	3.06	11.43	2.04	3.47	1.22	0.00	3.27	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	72.20	2.49	10.46	1.00	1.99	0.50	0.00	7.97	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	32.78	3.88	5.99	1.41	3.88	1.76	0.00	5.99	1.41	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	83.62	31.13	9.16	0.00	0.61	0.61	0.00	7.32	29.30	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	42.22	19.24	4.52	1.57	0.39	0.20	0.00	2.75	15.12	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	53.32	14.98	3.30	0.76	0.25	0.25	0.25	1.52	13.71	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	31.58	5.07	1.69	2.82	0.00	0.00	0.00	2.82	1.69	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	44.93	9.81	2.07	1.55	0.26	0.00	0.00	4.39	4.39	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	55.80	8.73	2.66	1.14	0.00	0.00	0.00	5.69	4.18	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	60.43	16.93	3.80	0.88	0.00	0.00	0.00	9.34	3.50	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	47.83	16.37	4.09	1.51	0.43	0.00	0.00	5.82	1.94	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	52.97	17.52	3.75	2.50	0.83	0.42	0.00	4.17	2.92	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	76.72	8.76	6.39	2.13	0.47	0.24	0.00	1.89	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	60.75	10.61	7.07	0.96	0.48	0.48	0.16	6.43	0.48	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	61.27	11.45	6.06	0.67	0.00	0.00	0.67	2.69	2.02	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.34	20.50	2.82	1.41	0.63	0.31	0.00	2.35	25.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.36	13.26	0.98	0.00	0.00	0.00	0.00	2.46	21.62	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	60.22	41.02	5.24	0.87	1.75	0.00	0.00	6.98	43.64	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	46.77	6.87	1.91	1.72	0.57	0.00	0.00	8.40	6.30	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	44.48	5.23	2.18	0.00	0.00	0.44	0.00	3.92	3.92	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	45.48	8.00	3.50	0.50	0.00	0.00	0.00	13.49	5.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	26.56	10.74	3.77	2.83	0.00	0.00	0.00	9.23	1.51	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	23.65	9.55	2.27	2.27	0.45	0.00	0.00	10.46	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	34.77	9.71	4.07	3.13	0.00	0.31	0.00	15.98	1.88	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	40.34	8.33	5.55	0.82	0.65	0.82	0.16	8.00	2.94	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	35.13	14.23	6.68	1.16	0.29	0.00	0.29	4.06	3.48	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	34.08	11.06	5.38	0.90	0.00	0.60	0.00	9.27	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	44.52	19.03	2.96	0.92	0.92	0.74	0.00	2.96	10.53	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	35.66	15.41	4.56	0.57	0.57	0.29	0.00	2.00	8.84	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	73.90	26.54	7.76	2.45	1.63	0.00	0.00	3.27	16.33	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	46.12	9.51	1.41	1.06	0.35	0.00	0.00	2.11	1.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	38.33	7.29	1.90	0.63	0.00	1.27	0.00	5.07	2.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	43.88	7.87	2.42	3.03	0.61	0.61	0.00	5.75	2.42	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	41.37	10.86	5.69	2.59	1.03	0.00	0.00	4.65	1.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	31.22	9.30	2.66	1.33	0.66	0.66	0.00	13.95	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	47.20	13.85	4.87	1.03	0.26	0.51	0.00	4.87	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	46.27	9.97	5.62	1.28	0.77	1.02	0.26	5.37	1.28	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	49.98	16.66	7.57	1.51	1.51	0.00	0.00	2.27	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	49.74	12.43	4.37	1.01	1.34	0.67	0.67	6.05	1.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	45.16	23.43	5.07	0.72	0.72	0.24	0.48	2.42	8.69	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	51.25	16.94	8.02	0.45	1.34	0.00	0.00	3.57	10.25	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	46.83	21.46	4.39	0.49	0.00	0.49	0.00	3.41	13.17	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	42.48	7.03	3.36	0.61	0.00	0.00	0.31	4.28	2.75	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	292.79	48.80	22.77	3.25	0.00	3.25	0.00	45.55	26.03	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	68.17	15.89	2.98	1.65	0.33	0.33	0.00	10.59	4.63	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	43.24	13.68	3.28	0.55	0.55	0.00	0.00	7.11	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	42.34	9.41	2.53	2.17	0.36	0.00	0.00	10.86	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	45.55	9.61	2.49	1.07	0.36	0.00	0.00	6.41	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	40.58	16.71	1.19	1.19	1.19	0.00	0.00	5.97	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	74.08	10.43	7.72	1.22	0.41	0.68	0.00	3.79	1.08	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	44.18	9.16	4.85	0.81	1.08	0.54	0.00	7.00	0.54	0.00
immature langerhans cells, donor1	11904-125F5	65.14	0.00	9.44	0.97	1.70	0.24	0.00	5.09	0.00	1.94
immature langerhans cells, donor2	11905-125F6	44.36	0.00	2.38	0.00	0.00	0.00	0.00	1.58	0.00	0.79
insula, adult, pool1	10039-101F3	94.92	5.20	12.49	1.32	6.53	3.60	0.85	4.73	1.04	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	40.32	0.33	0.65	2.28	1.95	2.28	0.00	2.93	0.00	0.00
kidney, adult, pool1	10017-101C8	66.78	2.20	3.10	1.30	3.90	1.90	0.40	2.20	0.20	0.40
kidney, fetal, pool1	10045-101F9	47.53	5.87	2.33	1.06	1.13	0.35	0.00	4.31	0.21	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	107.79	15.48	11.50	3.12	1.99	0.28	0.14	4.26	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	45.62	2.07	0.41	0.55	0.69	0.41	0.00	1.11	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	65.33	1.28	1.10	2.02	0.55	0.37	0.18	1.47	0.00	0.00
left atrium, adult, donor1	10079-102A7	31.60	0.54	1.09	2.18	1.09	0.54	0.00	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	29.33	0.00	0.51	0.00	1.52	0.00	0.00	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	43.78	1.64	1.92	1.64	1.09	1.64	0.27	0.55	1.64	0.00
leiomyoma cell line:10964C	10569-108B2	15.45	0.72	1.44	0.36	1.44	0.36	0.36	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	23.91	1.63	1.09	1.09	1.63	1.09	0.00	0.00	1.09	0.00
leiomyoma cell line:15425	10571-108B4	27.68	0.24	1.46	0.00	0.49	0.49	0.73	0.00	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	53.32	0.00	0.00	2.09	2.09	3.14	0.00	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	62.57	6.02	11.45	1.06	0.24	0.24	0.12	5.55	55.37	0.94
liposarcoma cell line:KMLS-1	10782-110G8	35.93	1.72	2.81	0.47	0.62	0.31	0.00	1.56	1.09	0.00
liposarcoma cell line:SW 872	10726-110A6	48.61	2.56	2.31	0.49	0.24	0.85	0.24	0.61	0.61	0.00
liver, adult, pool1	10018-101C9	49.59	0.16	1.78	0.97	1.94	1.30	0.00	0.49	0.00	0.00
liver, fetal, pool1	10086-102B5	11.29	0.00	0.00	1.88	0.00	0.00	0.00	2.82	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	67.81	1.46	5.25	3.94	1.90	0.73	0.15	3.79	0.73	0.00
locus coeruleus, adult, donor10252	10165-103B3	92.46	2.03	7.75	2.40	0.74	0.74	0.37	5.54	0.74	0.37
locus coeruleus, adult, donor10258	10375-105G6	35.83	1.97	5.64	0.56	1.13	0.28	0.00	2.82	1.69	0.00
locus coeruleus, newborn, donor10223	10362-105F2	59.73	5.05	7.99	0.84	1.26	0.84	0.00	4.63	1.26	3.36
lung adenocarcinoma cell line:A549	10499-107C4	34.60	2.91	1.11	0.69	0.97	0.55	0.00	0.55	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	45.50	0.00	1.38	1.38	3.45	0.00	0.00	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	66.70	0.00	1.32	1.19	2.77	1.71	0.26	0.53	0.26	0.00
lung, adult, pool1	10019-101D1	42.41	0.47	0.71	1.42	1.18	0.71	0.24	2.36	0.00	0.12
lung, fetal, donor1	10068-101I5	78.49	4.00	4.28	1.71	2.00	0.29	0.00	6.85	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	29.33	0.46	0.46	0.46	0.00	0.46	0.46	5.04	0.00	0.00
lymph node, adult, donor1	10077-102A5	30.77	0.47	0.95	0.00	0.00	0.95	0.00	3.79	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	55.23	0.88	1.32	0.88	0.00	0.00	0.00	2.41	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	99.76	8.15	5.28	2.72	0.00	0.15	0.00	3.92	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	84.10	0.85	7.65	0.85	1.70	1.70	0.00	9.34	0.85	0.00
mature adipocyte, donor1	12231-129F8	46.17	0.00	0.44	0.44	2.22	0.00	0.00	1.78	0.00	0.00
mature adipocyte, donor2	12232-129F9	37.15	0.62	0.83	0.00	0.00	0.42	0.00	1.66	0.00	0.00
mature adipocyte, donor3	12233-129G1	49.78	0.24	1.66	0.95	0.24	0.71	0.00	1.19	0.00	0.00
mature adipocyte, donor4	12234-129G2	65.54	0.26	1.05	1.32	0.00	0.79	0.00	0.79	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	74.58	3.81	2.38	1.43	0.95	0.95	0.24	5.24	0.48	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	95.88	3.38	4.51	2.26	9.02	2.26	1.13	5.64	6.77	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	112.55	1.66	5.89	4.23	2.57	1.84	0.00	5.15	1.47	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	55.60	2.22	6.04	0.64	4.45	1.59	0.00	2.54	1.27	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	84.02	11.94	11.09	1.71	5.97	3.41	1.71	8.10	8.53	4.26
medial temporal gyrus - adult, donor10196	10183-103D3	89.94	2.70	11.31	2.36	9.11	4.22	0.00	4.22	2.36	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	109.93	1.06	9.55	1.91	3.61	1.49	0.21	7.85	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	0.00	5.78	0.00	5.78	1.93	0.00	9.63	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	617.21	28.71	186.60	0.00	14.35	28.71	0.00	473.67	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	49.53	4.67	5.03	1.08	1.44	2.51	2.15	6.10	2.51	1.79
medulla oblongata - adult, donor10196	10174-103C3	55.16	1.30	1.95	1.30	3.24	1.30	1.95	8.44	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	99.54	3.87	4.33	2.79	1.70	1.08	0.15	5.26	0.15	0.15
medulla oblongata, adult, pool1	10038-101F2	67.59	3.18	6.94	1.47	1.47	0.98	0.16	3.27	1.06	0.08
medulla oblongata, newborn, donor10223	10361-105F1	42.36	4.86	2.78	2.08	2.08	0.69	0.69	2.08	1.39	0.00
medulloblastoma cell line:D283 Med	10838-111E1	123.33	15.50	17.27	1.33	0.22	0.44	0.00	7.53	15.94	0.22
medulloblastoma cell line:ONS-76	10759-110E3	73.73	2.57	2.93	2.32	1.35	1.96	0.49	0.73	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	54.19	2.16	2.01	1.15	1.44	1.15	0.00	0.86	0.72	0.14
melanoma cell line:G-361	10465-106H6	79.27	3.53	2.99	1.09	1.90	0.54	0.27	3.53	1.63	0.00
meningioma cell line:HKBMM	10691-109F7	28.76	0.54	0.00	0.90	0.90	0.54	0.00	0.36	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	118.08	9.69	5.29	1.76	2.64	0.88	0.00	9.69	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	142.83	11.92	9.59	4.41	1.30	2.07	0.26	6.22	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	64.90	1.69	1.69	0.77	0.46	0.77	0.31	0.31	1.07	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	45.08	2.18	1.09	0.73	0.00	0.55	0.00	0.73	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	33.13	0.41	1.24	0.41	0.00	0.41	0.41	0.00	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	43.27	0.28	0.56	0.56	0.56	1.26	0.14	0.28	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	32.74	1.93	0.77	0.39	0.58	0.58	0.19	0.58	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	43.73	1.39	0.69	0.69	0.69	0.69	0.00	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	34.33	0.34	0.34	0.69	1.20	0.86	0.34	0.34	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	37.73	0.58	0.46	1.27	1.15	0.69	0.23	0.58	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	42.71	1.19	2.12	1.19	0.40	0.66	0.40	0.13	0.27	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	43.21	1.35	0.81	0.95	0.81	1.35	0.41	0.41	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	54.77	0.57	1.42	0.71	1.71	1.28	0.71	0.28	0.85	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	37.88	0.66	0.33	0.33	0.66	0.33	0.66	3.95	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	39.85	1.25	0.83	0.55	0.55	1.11	0.55	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	37.70	0.70	0.00	1.05	1.40	0.00	0.35	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	39.20	0.61	0.82	0.61	1.22	1.84	0.41	0.00	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	34.15	1.08	0.72	1.08	1.80	0.36	0.00	1.44	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.41	0.72	0.21	0.31	0.83	0.52	0.00	0.31	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	23.71	0.46	0.68	0.68	1.37	1.14	0.00	1.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	67.55	2.10	4.62	1.26	2.52	0.84	0.42	0.42	1.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	47.07	1.20	0.60	0.30	0.60	0.75	0.15	0.30	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	42.10	1.05	0.35	1.23	1.58	2.28	0.26	0.18	0.44	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	39.39	0.37	0.37	0.74	1.84	1.10	0.00	1.84	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	29.76	0.00	1.43	1.14	0.57	1.14	0.29	2.86	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	64.42	2.11	3.79	0.84	1.68	0.84	0.00	0.42	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	29.68	2.28	1.37	0.00	0.46	1.83	0.00	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	38.11	2.30	2.30	0.51	0.26	1.02	0.00	1.28	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	36.12	0.79	1.57	0.26	0.79	1.05	0.26	2.88	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.96	1.23	0.92	0.00	0.31	0.31	0.00	1.85	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	37.89	1.41	2.82	0.71	1.88	0.24	0.24	0.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	29.11	1.02	2.03	0.00	0.34	0.00	0.00	1.35	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	37.33	1.18	1.57	0.79	0.39	0.39	0.00	1.18	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	34.29	0.93	1.39	0.00	0.46	0.00	0.46	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	43.55	0.87	3.46	0.58	1.15	0.87	0.29	0.87	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	27.89	3.12	1.56	0.22	0.45	0.22	0.22	1.34	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	33.89	0.96	0.72	0.24	0.48	0.24	0.48	0.72	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	38.87	0.73	2.20	0.73	1.47	1.47	1.47	2.20	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	30.21	1.01	2.01	1.01	1.34	1.68	0.00	1.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	29.07	1.23	2.46	0.41	1.23	0.00	0.41	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	29.64	3.44	1.29	0.43	0.86	1.29	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	0.00	0.00	0.00	0.00	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	39.30	1.30	0.32	1.30	0.32	1.30	0.32	1.30	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	0.00	1.45	1.45	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	25.59	2.13	2.13	1.07	1.60	0.53	0.53	1.60	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.90	0.82	0.00	1.64	0.82	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	29.54	0.78	2.33	1.55	0.39	0.39	0.00	1.55	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	29.38	2.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	30.80	0.00	2.98	0.00	0.99	0.00	0.00	2.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	26.68	2.96	1.78	0.00	0.59	0.59	0.59	1.78	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	23.15	1.22	1.22	0.00	0.00	0.00	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.04	3.17	1.27	0.63	0.63	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	27.94	2.07	1.72	0.34	0.69	0.34	0.00	1.03	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	2.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	0.00	3.99	0.00	0.00	0.00	0.00	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	0.00	0.00	3.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.82	0.81	0.00	0.00	0.41	0.41	0.00	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	28.60	3.18	0.00	0.00	0.00	0.00	0.00	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	21.81	2.36	0.59	0.59	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	26.49	3.12	0.94	0.00	0.00	0.00	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	29.41	1.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	1.18	1.18	0.00	0.00	0.00	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	33.04	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	36.12	0.49	0.99	2.97	0.00	0.00	0.49	0.99	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	22.43	1.12	0.00	3.36	0.00	0.00	0.00	3.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	34.98	1.27	1.27	1.91	0.00	1.27	0.00	1.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	23.37	0.81	0.00	2.01	0.40	0.40	0.00	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	21.54	0.00	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	30.34	0.00	0.61	0.00	0.00	0.00	0.00	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	0.00	0.00	4.52	0.00	0.00	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	26.36	1.65	0.00	0.82	0.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	25.40	0.99	0.40	0.40	0.40	0.20	0.00	0.40	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	23.36	1.30	1.30	0.32	0.00	0.32	0.00	1.62	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	18.34	0.00	0.00	0.00	1.02	0.00	0.00	2.04	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	49.52	1.55	0.77	0.77	0.00	0.77	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	72.76	1.18	0.94	0.94	7.09	5.43	0.24	2.36	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	45.18	7.88	4.17	1.16	1.39	2.09	0.23	2.55	0.70	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	8.55	0.00	0.00	0.00	0.00	0.00	8.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	36.37	2.88	2.98	0.41	0.62	0.62	0.10	1.44	0.00	0.10
mesothelioma cell line:Mero-25	10850-111F4	25.87	4.54	2.27	0.23	0.45	0.23	0.00	1.82	1.13	0.00
mesothelioma cell line:Mero-41	10851-111F5	72.12	1.96	2.93	1.96	1.96	1.22	0.00	2.69	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	58.01	2.21	3.54	1.33	2.66	1.55	0.00	1.11	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	75.16	5.52	10.25	0.26	1.31	0.79	0.53	2.10	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	73.37	5.28	3.23	0.85	1.53	1.02	0.34	2.72	0.17	0.00
mesothelioma cell line:Mero-84	10855-111F9	30.59	3.03	3.03	0.76	1.52	0.25	0.00	1.77	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	41.82	3.93	2.48	0.62	2.48	1.66	0.21	2.07	0.00	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	62.28	2.32	2.48	1.33	1.49	1.49	0.33	1.16	2.15	0.00
mesothelioma cell line:NCI-H226	10846-111E9	55.38	6.33	5.07	0.90	1.09	0.90	0.00	2.71	0.36	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	84.90	2.22	3.07	2.22	2.90	2.39	0.34	1.88	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	80.67	1.78	1.27	2.80	2.29	1.53	0.25	4.07	0.00	0.25
mesothelioma cell line:No36	10857-111G2	48.60	1.96	1.63	1.30	0.98	0.00	0.00	0.65	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	66.11	0.54	1.35	1.90	1.90	0.81	0.00	0.81	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	77.54	1.54	1.92	2.30	0.19	0.19	0.00	9.21	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	63.50	1.34	1.95	2.20	0.12	0.37	0.00	1.34	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	84.71	2.33	3.41	1.97	0.00	0.00	0.00	2.51	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	60.73	0.33	1.96	0.00	0.65	1.31	0.00	1.96	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	28.40	2.54	3.18	0.85	0.00	0.21	0.21	1.91	1.70	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	81.78	0.00	2.76	2.76	2.99	1.15	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	51.19	1.52	1.33	0.57	0.00	0.19	0.00	2.09	1.14	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	131.57	1.11	0.74	3.14	0.37	0.18	0.00	5.91	10.53	0.00
myeloma cell line:PCM6	10474-106I6	40.92	1.38	0.79	1.58	0.20	0.00	0.00	1.58	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	43.63	1.52	2.03	1.52	2.54	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	36.29	0.39	0.78	0.39	0.20	0.98	0.78	0.98	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	19.95	0.11	1.00	0.56	0.56	0.45	0.00	0.45	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	20.74	0.07	1.47	0.59	0.29	0.15	0.00	0.88	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	71.21	0.00	3.31	1.10	0.55	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	190.72	67.18	16.56	3.22	0.23	0.46	0.00	21.40	2.76	0.23
neuroblastoma cell line:NB-1	10539-107G8	91.11	5.61	5.05	1.12	2.06	0.94	0.19	5.05	2.81	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	80.56	17.29	4.43	1.27	0.84	0.00	0.00	1.69	1.27	0.00
neuroblastoma cell line:NH-12	10555-107I6	130.07	38.02	4.85	1.49	0.00	0.00	0.00	12.49	0.37	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	61.44	23.25	1.19	2.61	0.47	0.71	0.00	11.86	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	56.70	14.41	1.27	1.11	0.48	0.16	0.32	6.97	0.48	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	49.31	16.30	1.21	1.01	0.60	0.40	0.00	3.62	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	65.48	8.90	0.00	1.27	3.18	0.64	0.00	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	35.40	0.53	1.86	2.13	1.60	0.80	0.00	2.66	0.27	0.00
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	106.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	161.34	20.13	1.52	3.38	0.00	0.00	0.17	15.56	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	97.66	3.20	6.40	2.40	2.40	2.40	0.00	2.40	8.81	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	31.10	3.53	2.56	0.32	0.32	0.32	0.00	1.28	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	37.05	1.05	2.10	0.79	2.36	2.36	0.26	1.05	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	93.36	3.28	15.09	0.75	8.81	4.12	0.84	3.47	0.94	0.09
occipital cortex - adult, donor10196	10172-103C1	84.48	2.06	8.24	2.06	4.12	0.00	0.00	10.30	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	112.98	1.88	5.90	1.61	1.88	0.54	0.00	8.59	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	68.42	5.82	7.28	3.64	3.64	0.73	1.09	4.37	4.37	2.91
occipital lobe, adult, donor1	10076-102A4	52.48	3.15	5.51	0.26	2.89	1.57	0.26	4.20	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	49.78	18.45	4.72	1.72	1.72	2.15	0.00	9.01	0.00	0.00
occipital pole, adult, pool1	10036-101E9	52.04	1.97	5.60	0.71	2.44	0.87	0.08	1.97	0.63	0.00
olfactory region, adult	10195-103E6	65.53	1.91	8.98	1.15	4.78	0.96	0.38	3.06	0.19	0.00
optic nerve, donor1	10277-104E7	72.04	2.00	6.00	2.00	0.00	0.00	0.00	6.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	54.33	0.57	2.05	1.14	1.37	0.68	0.11	0.46	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	65.12	2.20	0.27	2.47	0.69	0.27	0.00	2.61	2.61	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	69.08	1.19	1.52	1.69	2.71	1.35	0.17	1.19	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	46.55	1.04	2.19	0.92	1.27	0.12	0.12	0.46	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	41.74	0.59	0.59	1.47	0.59	0.59	0.00	1.76	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	84.09	1.87	3.74	0.93	2.80	1.87	0.00	1.87	6.54	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	54.29	2.97	1.06	1.48	0.00	0.42	0.00	3.61	9.33	0.00
ovary, adult, pool1	10020-101D2	44.11	2.18	2.80	1.31	0.79	0.79	0.09	1.92	0.09	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.03	1.65	1.10	1.47	0.37	0.00	0.00	3.48	4.40	0.00
pancreas, adult, donor1	10049-101G4	36.68	0.00	4.70	0.00	0.00	0.00	0.00	4.70	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	57.30	0.84	1.40	0.56	0.84	0.28	0.00	6.71	4.75	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	77.00	3.75	1.36	2.38	1.53	1.70	0.17	3.24	0.34	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	74.35	1.66	1.66	2.15	1.82	0.99	0.33	5.13	0.99	0.00
paracentral gyrus, adult, pool1	10035-101E8	93.44	3.75	10.25	1.01	3.94	2.20	0.37	3.66	0.92	0.09
parietal cortex, adult, donor10258	10373-105G4	100.56	3.67	9.54	2.20	6.61	1.47	0.00	4.40	1.47	0.73
parietal lobe - adult, donor10196	10171-103B9	73.36	0.94	8.46	1.88	4.70	0.00	0.00	4.70	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	122.28	2.00	7.98	1.14	3.71	1.14	0.00	5.70	1.14	0.29
parietal lobe, adult, pool1	10034-101E7	86.27	2.64	11.37	1.23	3.08	1.50	0.18	3.79	0.62	0.00
parietal lobe, fetal, donor1	10072-101I9	68.86	19.40	4.85	1.94	0.00	0.97	0.00	14.55	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	59.82	5.61	10.47	4.49	4.11	3.36	2.99	5.23	5.61	1.12
parotid gland, adult	10199-103F1	62.90	0.00	1.23	0.62	1.23	1.23	0.00	1.23	0.00	0.00
penis, adult	10200-103F2	52.64	0.54	0.54	0.00	0.54	1.07	0.00	6.98	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	91.29	8.00	3.16	0.93	2.05	2.05	0.00	6.51	2.05	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	31.91	1.46	0.58	0.58	1.02	0.73	0.00	1.31	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	57.41	1.94	7.74	2.58	0.65	0.00	0.00	3.87	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	118.44	5.33	14.81	1.78	1.18	0.00	0.00	21.32	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	53.30	1.88	12.54	1.88	0.00	1.88	0.00	3.76	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	89.04	2.02	3.04	1.01	8.09	3.04	0.00	8.09	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	181.37	4.17	8.86	2.08	3.13	4.17	0.00	17.72	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	65.55	4.26	2.55	0.00	4.26	5.11	0.00	28.09	0.00	0.00
placenta, adult, pool1	10021-101D3	46.98	1.51	1.83	0.97	1.08	0.75	0.11	3.23	0.32	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	76.94	1.46	0.93	1.99	0.13	0.26	0.00	1.85	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	29.42	0.31	1.25	0.47	0.31	0.78	0.31	1.71	0.16	0.00
pons, adult, pool1	10033-101E6	112.23	5.59	12.39	2.32	1.72	1.55	0.17	2.50	4.05	0.09
postcentral gyrus, adult, pool1	10032-101E5	65.56	2.62	7.50	1.22	2.62	1.22	0.26	4.01	1.48	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	85.75	0.00	0.00	2.09	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	0.00	0.00	5.51	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	71.96	2.33	1.75	1.17	1.60	1.46	0.15	1.89	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	48.46	2.72	2.54	0.73	1.45	1.63	0.00	1.63	2.36	0.00
prostate, adult, pool1	10022-101D4	40.36	0.82	1.54	0.63	0.82	0.27	0.09	2.72	0.18	0.00
putamen, adult, donor10196	10176-103C5	98.20	4.49	20.54	0.71	17.70	4.01	0.71	8.73	1.65	0.47
putamen, adult, donor10252	10152-102I8	80.39	0.00	0.00	3.92	1.96	5.88	0.00	5.88	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	39.34	7.65	5.46	0.00	6.56	0.00	0.00	2.19	10.93	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	68.13	1.69	9.42	0.72	14.26	6.04	0.24	3.62	0.97	0.00
putamen, newborn, donor10223	10365-105F5	59.22	6.75	10.50	2.25	3.75	2.25	0.00	11.24	3.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	53.24	1.16	0.87	0.87	1.45	1.16	0.00	0.58	1.45	0.00
rectum, fetal, donor1	10067-101I4	41.73	5.56	2.78	4.17	0.00	1.39	0.00	20.86	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	51.09	0.21	0.85	1.06	1.27	0.21	0.00	1.48	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	55.92	0.00	1.24	0.83	2.07	0.41	0.41	6.63	0.00	0.00
retina, adult, pool1	10030-101E3	61.03	3.08	4.97	1.39	0.60	0.60	0.00	4.67	0.40	0.00
retinoblastoma cell line:Y79	10475-106I7	78.98	16.11	7.01	1.30	0.00	0.00	0.00	7.53	3.64	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	41.56	8.85	3.44	1.35	1.84	0.98	0.37	3.69	6.39	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	84.92	17.43	11.81	0.84	1.97	0.56	0.00	5.06	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	37.89	1.52	0.00	0.76	0.00	2.27	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	53.90	1.13	2.27	0.97	0.32	0.49	0.16	2.43	0.00	0.00
salivary acinar cells, donor2	11772-123I8	37.18	0.55	2.48	0.28	0.55	0.14	0.00	3.17	0.00	0.00
salivary acinar cells, donor3	11773-123I9	36.41	0.00	1.32	0.00	1.32	0.00	0.00	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	57.77	0.00	1.14	1.72	0.00	1.72	0.57	5.72	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	93.25	2.70	0.51	1.85	7.59	5.48	0.34	1.26	0.76	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	82.87	2.35	1.06	2.00	8.93	5.76	0.71	1.76	1.06	0.12
seminal vesicle, adult	10201-103F3	42.85	0.00	0.53	1.06	2.65	1.59	0.00	6.88	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	40.08	0.24	1.46	0.73	1.94	0.73	0.00	2.67	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	60.64	1.01	0.50	1.76	2.01	0.75	0.50	1.01	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	74.26	0.00	3.01	6.02	0.00	2.01	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	88.65	2.96	3.36	1.34	2.01	1.21	0.13	2.42	3.36	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	150.76	0.88	2.43	4.64	3.54	1.88	0.33	3.87	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	143.73	4.13	6.19	1.42	4.39	2.06	0.13	4.13	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	85.83	0.71	3.55	5.67	0.71	0.00	0.00	6.38	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	62.01	0.24	1.56	1.44	0.24	0.24	0.00	1.08	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	18.09	3.02	1.01	3.02	0.00	0.00	0.00	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00	0.00	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	46.08	3.79	2.52	0.63	2.52	0.63	0.00	8.21	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	52.36	5.00	0.67	1.67	1.00	1.00	0.00	3.00	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	60.83	11.35	5.99	2.21	0.00	0.63	0.00	10.40	13.55	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	78.45	9.64	2.51	0.58	1.73	0.96	0.39	3.47	1.16	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	203.23	3.46	7.91	3.79	1.81	0.66	0.16	8.24	3.96	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	105.84	1.45	1.45	4.66	0.00	0.00	0.32	7.72	8.20	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	57.75	1.09	3.92	0.65	0.87	0.87	0.00	2.40	1.09	0.00
small intestine, adult, pool1	10024-101D6	66.89	0.72	1.91	1.43	1.43	0.36	0.00	3.22	0.12	1.07
small intestine, fetal, donor1	10064-101I1	42.51	2.70	2.46	0.49	0.74	0.74	0.00	6.88	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	37.44	1.03	2.56	1.54	1.54	1.03	0.00	2.05	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	39.03	0.26	1.29	0.78	0.00	0.00	0.00	3.10	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	52.53	0.00	1.88	1.61	1.61	1.07	0.00	1.07	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	70.43	1.61	5.05	2.52	1.61	1.38	0.00	8.26	0.46	0.23
spinal cord, adult, donor10252	10159-103A6	77.28	1.97	4.34	0.79	1.97	1.97	0.39	8.28	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	47.04	2.08	2.08	2.08	1.38	0.00	0.00	6.92	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	50.62	4.88	4.27	1.22	2.44	0.00	0.00	11.59	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	76.69	2.30	4.59	2.76	1.38	0.00	0.00	4.13	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	39.13	0.30	1.49	1.19	1.05	1.34	0.75	0.60	0.30	0.00
spleen, adult, pool1	10025-101D7	56.17	1.43	0.33	1.65	0.55	0.22	0.22	1.54	0.00	0.11
spleen, fetal, pool1	10044-101F8	57.21	2.07	0.56	1.67	0.24	0.40	0.16	3.42	0.16	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	83.84	3.11	3.73	1.76	0.21	0.31	0.00	6.83	1.35	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	34.18	0.38	1.33	0.38	2.28	0.57	0.00	1.71	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	53.47	2.10	2.80	0.70	2.10	1.40	0.70	3.84	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	34.01	0.39	2.74	0.39	0.78	1.56	0.00	0.78	1.17	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	92.19	1.13	8.22	1.69	2.81	1.13	0.23	2.70	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	59.73	3.81	2.54	1.27	2.12	0.42	0.00	2.54	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	48.65	2.12	0.42	1.27	1.69	0.42	0.00	1.27	0.85	0.00
stomach, fetal, donor1	10062-101H8	41.65	1.07	0.00	0.00	0.00	0.00	0.00	7.48	0.00	0.00
submaxillary gland, adult	10202-103F4	47.85	0.00	1.71	0.57	0.00	0.57	0.00	3.42	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	54.27	0.00	0.00	0.00	0.00	1031.21	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	80.80	1.04	3.53	1.87	0.83	0.42	0.00	7.89	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	63.10	2.59	8.79	2.07	2.07	0.00	0.00	4.14	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	45.93	3.53	0.00	1.41	0.71	0.71	0.00	9.19	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	84.14	14.44	6.19	1.60	2.98	1.83	0.00	2.29	4.36	0.00
temporal lobe, adult, pool1	10031-101E4	49.00	2.71	7.80	0.68	2.88	1.61	0.42	2.63	0.85	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	59.12	9.97	3.56	0.00	1.42	1.42	0.00	6.41	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	53.18	8.79	8.35	1.32	1.32	0.44	0.44	8.79	1.32	0.00
tenocyte, donor1	11763-123H8	37.70	1.05	1.75	0.00	1.05	0.70	0.00	2.09	0.00	0.00
tenocyte, donor2	11765-123I1	32.43	0.38	0.00	0.76	1.91	0.00	0.76	2.29	0.38	0.00
tenocyte, donor3	11768-123I4	31.14	1.11	1.48	0.74	1.48	0.37	0.74	3.34	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	89.74	46.23	6.12	3.57	1.02	0.34	0.00	5.95	54.39	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	46.86	8.79	2.31	1.39	0.15	0.62	0.00	4.01	11.41	0.15
teratocarcinoma cell line:PA-1	10807-111A6	50.06	7.59	2.17	1.24	0.00	0.62	0.15	2.01	1.39	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	54.33	3.81	4.06	1.90	0.51	0.13	0.38	5.08	36.31	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	111.94	9.08	6.81	2.65	0.76	0.00	0.00	9.45	24.20	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	74.71	3.60	3.27	0.98	0.22	0.22	0.11	2.62	11.67	1.74
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	71.00	5.21	3.91	1.63	0.98	0.00	0.00	4.56	13.03	0.00
testis, adult, pool1	10026-101D8	45.31	3.44	3.33	1.72	0.54	0.54	0.00	2.15	0.21	0.43
testis, adult, pool2	10096-102C6	62.25	4.96	2.71	2.71	1.35	0.00	0.00	5.41	0.45	0.45
thalamus - adult, donor10196	10168-103B6	73.97	1.10	5.52	2.21	3.31	1.10	0.00	16.56	0.00	0.00
thalamus, adult, donor10252	10154-103A1	100.02	2.50	6.56	2.03	2.81	2.03	0.16	8.28	0.31	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	33.87	1.54	4.62	1.54	4.62	1.54	0.00	12.32	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	29.64	1.48	3.62	0.99	1.32	0.82	0.49	3.29	0.49	0.00
thalamus, newborn, donor10223	10366-105F6	38.55	1.73	9.78	2.30	4.60	5.18	2.30	4.03	2.30	2.30
throat, adult	10209-103G2	54.18	0.00	1.75	1.00	0.75	0.75	0.00	4.49	0.00	0.25
throat, fetal, donor1	10061-101H7	38.39	3.96	1.22	1.83	0.30	0.61	0.30	6.09	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	68.76	20.27	5.56	1.99	2.19	0.99	0.60	9.74	2.98	0.00
thymus, adult, pool1	10027-101D9	73.57	11.04	2.78	1.39	0.50	0.40	0.10	1.79	0.00	0.30
thymus, fetal, pool1	10043-101F7	95.59	18.70	3.43	2.49	0.21	0.31	0.10	7.48	0.21	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	48.40	0.40	1.06	1.46	1.20	0.80	0.00	1.33	3.72	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	56.99	1.82	0.56	0.70	0.70	0.28	0.00	4.47	0.42	0.00
thyroid, adult, pool1	10028-101E1	61.96	1.68	1.87	0.56	1.31	1.12	0.00	1.87	0.00	0.00
thyroid, fetal, donor1	10060-101H6	41.66	1.05	2.11	1.32	0.53	0.79	0.00	9.49	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	92.39	0.00	12.32	3.08	3.08	0.00	0.00	18.48	0.00	0.00
tongue, adult	10203-103F5	62.33	0.70	2.33	0.70	0.93	0.70	0.00	2.09	0.00	0.00
tongue, fetal, donor1	10059-101H5	45.32	0.39	1.97	1.18	0.39	0.00	0.39	0.79	0.00	0.00
tonsil, adult, pool1	10047-101G2	75.73	1.00	1.70	1.60	1.20	0.30	0.20	5.71	0.00	0.00
trachea, adult, pool1	10029-101E2	56.69	1.15	1.23	0.74	1.88	0.49	0.00	2.70	0.74	0.00
trachea, fetal, donor1	10058-101H4	43.86	1.92	1.92	0.77	1.15	0.38	0.00	4.23	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	38.62	1.06	3.19	0.71	1.06	1.06	0.00	3.54	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	110.54	5.17	9.32	1.52	1.32	0.61	0.20	3.95	0.91	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	69.41	1.57	2.51	0.94	1.41	0.47	0.31	4.23	2.82	0.00
tridermal teratoma cell line:HGRT	10694-109G1	55.17	1.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	46.73	2.62	0.68	0.68	2.45	1.19	0.25	2.29	1.52	0.00
umbilical cord, fetal, donor1	10057-101H3	31.30	0.00	0.00	0.00	0.00	0.00	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	55.45	1.37	2.05	1.54	0.34	0.34	0.00	5.97	0.00	0.00
uterus, fetal, donor1	10055-101H1	45.56	5.63	1.02	1.02	0.00	0.00	0.00	6.66	0.00	0.00
vagina, adult	10204-103F6	72.37	0.65	0.65	1.29	1.94	1.29	0.00	3.23	0.00	0.00
vein, adult	10191-103E2	54.36	2.41	1.10	1.53	0.66	0.00	0.00	2.63	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	49.40	2.40	0.80	0.00	0.53	0.00	0.27	1.34	0.53	0.00